SCP Private Credit Income BDC 10-Q6 Nov 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2024	Nov. 04, 2024
Cover [Abstract]
Document Type	10-Q
Document Transition Report	false
Document Quarterly Report	true
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Entity Registrant Name	SCP Private Credit Income BDC LLC
Entity Central Index Key	0001743415
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		18,532,519
Securities Act File Number	814-01294
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	500 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	993-1670
Entity Interactive Data Current	Yes
Entity Tax Identification Number	83-0634992
Entity Ex Transition Period	false

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands		Sep. 30, 2024	Dec. 31, 2023
Investments at fair value:
Cash		$ 63,967	$ 42,263
Interest receivable		3,719	3,290
Receivable for investments sold		96	40
Prepaid expenses		38	21
Total assets		422,160	466,182
Liabilities
Debt ($226,118 and $170,800 face amounts, respectively, reported net of unamortized debt issuance costs of $846 and $683, respectively. See note 5)		225,272	170,117
Distributions payable		0	15,152
Management fee payable (see note 3)		733	4,288
Incentive fee payable (see note 3)		3,443	4,449
Administration fee payable (see note 3)		77	95
Interest payable (see note 5)		1,325	3,400
Payable for investments purchased		56	0
Other liabilities and accrued expenses		246	380
Total liabilities		231,152	197,881
Commitments and contingencies (see note 6)
Unitholders' Capital
Common Unitholders' capital (18,532,519 and 26,710,775 units, respectively, issued and outstanding)		193,933	277,433
Accumulated distributable net loss		(2,925)	(9,132)
Total unitholders' capital		191,008	268,301
Total liabilities and unitholders' capital		$ 422,160	$ 466,182
Net asset value per unit	[1]	$ 10.31	$ 10.04
Companies less than 5% owned [Member]
Investments at fair value:
Investments, Fair Value Disclosure		$ 325,651	$ 406,610
Companies 5% to 25% owned [Member]
Investments at fair value:
Investments, Fair Value Disclosure		$ 28,689	$ 13,958

[1] Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively.

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024		Dec. 31, 2023
Debt Instrument face amount	$ 226,118		$ 170,800
Net of unamortized debt issuance costs	$ 846		$ 683
Common unit issued	18,532,519		26,710,775
Common unit outstanding	18,532,519	[1]	26,710,775
Companies less than 5% owned [Member]
Investments at cost	$ 323,997		$ 404,576
Companies 5% to 25% owned [Member]
Investments at cost	$ 35,744		$ 21,187

[1] Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively.

Consolidated Statements of Oper

Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Investment Income:
Total investment income	$ 12,069	$ 15,774	$ 37,164	$ 45,877
Expenses:
Management fees (see note 3)	733	1,102	2,805	3,238
Incentive fees (see note 3)	1,014	1,285	3,326	2,339
Administration fees (see note 3)	77	105	241	315
Interest and other credit facility expenses (see note 5)	4,188	5,722	11,217	17,824
Other general and administrative expenses	126	172	586	694
Total expenses	6,138	8,386	18,175	24,410
Net investment income	5,931	7,388	18,989	21,467
Realized and unrealized gain (loss) on investments:
Net realized gain	0	0	64	74
Net change in unrealized gain (loss)	(187)	(104)	(206)	(8,285)
Net realized and unrealized gain (loss) on investments	(187)	(104)	(142)	(8,211)
Net increase in unitholders' capital resulting from operations	$ 5,744	$ 7,284	$ 18,847	$ 13,256
Net Income (Loss) Per Unit	$ 0.22	$ 0.29	$ 0.71	$ 0.55
Companies less than 5% owned [Member]
Investment Income:
Interest income from non-controlled/non-affiliated investments	$ 11,956	$ 15,658	$ 36,760	$ 45,294
Other income from non-controlled/non-affiliated investments	63	103	354	570
Realized and unrealized gain (loss) on investments:
Net realized gain	0	0	64	74
Net change in unrealized gain (loss)	(360)	(1,045)	(379)	(7,155)
Companies 5% to 25% owned [Member]
Investment Income:
Interest income from non-controlled/non-affiliated investments	18	13	18	13
Dividends from non-controlled/non-affiliated investments	32	0	32	0
Realized and unrealized gain (loss) on investments:
Net change in unrealized gain (loss)	$ 173	$ 941	$ 173	$ (1,130)

Consolidated Statements of Chan

Consolidated Statements of Changes in Unitholders Capital (unaudited) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]
Net investment income		$ 5,931	$ 7,388	$ 18,989	$ 21,467
Net realized gain		0	0	64	74
Net change in unrealized gain (loss)		(187)	(104)	(206)	(8,285)
Net increase in unitholders' capital resulting from operations		5,744	7,284	18,847	13,256
Distributions to unitholders:
From net investment income		(7,640)	(6,537)	(12,640)	(6,537)
Increase in unitholders capital resulting from capital activity:
Contributions		0	0	0	65,000
Redemptions		(83,500)	0	(83,500)	0
Net increase in unitholders' capital resulting from capital activity		(83,500)	0	(83,500)	65,000
Total increase (decrease) in unitholders capital		(85,396)	747	(77,293)	71,719
Unitholders' capital, beginning of year		276,404	267,226	268,301	196,254
Unitholders' capital, end of year	[1]	$ 191,008	$ 267,973	$ 191,008	$ 267,973
Units issued		0	0	0	6,197,690
Partners' Capital Account, Units, Redeemed		8,178,256	0	8,178,256	0
Net increase from capital unit activity		(8,178,256)	0	(8,178,256)	6,197,690

[1] Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities:
Net increase in unitholders' capital resulting from operations	$ 18,847	$ 13,256
Adjustments to reconcile net increase in unitholders' capital resulting from operations to net cash provided by operating activities:
Net realized gain on investments	(64)	(74)
Net change in unrealized loss on investments	206	8,285
Deferred financing costs amortization	709	1,204
Net accretion of discount on investments	(1,606)	(2,511)
(Increase) decrease in operating assets:
Purchase of investments	(11,318)	(82,937)
Proceeds from disposition of investments	80,707	97,423
Capitalization of payment-in-kind income	(1,697)	(1,510)
Receivable for investments sold	(56)	(72)
Interest receivable	(429)	(198)
Prepaid expenses	(17)	(32)
Increase (decrease) in operating liabilities:
Management fee payable	(3,555)	2,719
Incentive fee payable	(1,006)	(700)
Administration fee payable	(18)	(3)
Interest payable	(2,075)	629
Payable for investments purchased	56	0
Other liabilities and accrued expenses	(134)	(467)
Net Cash Provided by Operating Activities	78,550	35,012
Cash Flows from Financing Activities:
Contributions from unitholders	0	65,000
Repurchases from unitholders	(83,500)	0
Cash distributions paid	(27,792)	(17,362)
Proceeds from borrowings	225,246	46,768
Repayments of borrowings	(170,800)	(131,126)
Net Cash Used in Financing Activities	(56,846)	(36,720)
NET INCREASE (DECREASE) IN CASH	21,704	(1,708)
CASH AT BEGINNING OF PERIOD	42,263	16,697
CASH AT END OF PERIOD	63,967	14,989
Supplemental disclosure of cash flow information:
Cash paid for interest	12,583	17,195
Non-cash purchase and disposition of investments	$ 9,577	$ 0

Consolidated Schedule of Invest

Consolidated Schedule of Investments - USD ($) $ in Thousands		9 Months Ended	12 Months Ended
		Sep. 30, 2024	Dec. 31, 2023	Jun. 16, 2023
Schedule of Investments [Line Items]
Spread above Index		600%
Interest rate, paid in kind		1%
Fair Value		$ 28,689	$ 13,958	$ 14,413
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Alimera Sciences, Inc Industry Pharmaceuticals Spread above Index S+515 Floor 4.60% Interest Rate 10.50% Acquisition Date 12/31/2019 Maturity Date 5/1/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		515%
Floor	[2]		4.60%
Interest Rate	[2],[3]		10.50%
Acquisition Date	[2]		Dec. 31, 2019
Maturity Date	[2]		May 01, 2028
Par Amount	[2]		$ 5,893
Cost	[2]		5,934
Fair Value	[2]		$ 6,080
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Basic Fun, Inc Industry Specialty Retail Spread above Index S+650 Floor 1.00% Interest Rate 12.14% Acquisition Date 10/30/2020 Maturity Date 7/2/2024
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		650%
Floor	[2]		1%
Interest Rate	[2],[3]		12.14%
Acquisition Date	[2]		Oct. 30, 2020
Maturity Date	[2]		Jul. 02, 2024
Par Amount	[2]		$ 960
Cost	[2]		958
Fair Value	[2]		$ 960
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Fertility (ITC) Investment Holdco, LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.97% Acquisition Date 1/4/2023 Maturity Date 1/3/2029
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		650%
Floor	[2]		1%
Interest Rate	[2],[3]		11.97%
Acquisition Date	[2]		Jan. 04, 2023
Maturity Date	[2]		Jan. 03, 2029
Par Amount	[2]		$ 10,278
Cost	[2]		10,007
Fair Value	[2]		$ 10,278
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Glooko, Inn Industry Health Care Technology Spread above Index S+790 Floor 0.10% Interest Rate 13.35% Acquisition Date 9/30/2021 Maturity Date 10/1/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		790%
Floor	[2]		0.10%
Interest Rate	[2],[3]		13.35%
Acquisition Date	[2]		Sep. 30, 2021
Maturity Date	[2]		Oct. 01, 2026
Par Amount	[2]		$ 1,769
Cost	[2]		1,792
Fair Value	[2]		$ 1,849
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Neuronetics, Inc Industry Health Care Equipment & Supplies Spread above Index S+565 Floor 3.95% Interest Rate 11.00% Acquisition Date 3/2/2020 Maturity Date 3/29/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		565%
Floor	[2]		3.95%
Interest Rate	[2],[3]		11%
Acquisition Date	[2]		Mar. 02, 2020
Maturity Date	[2]		Mar. 29, 2028
Par Amount	[2]		$ 5,238
Cost	[2]		5,259
Fair Value	[2]		$ 5,238
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Centrexion Therapeutics, Inc. Warrants Industry Pharmaceuticals Acquisition Date 6/28/2019
Schedule of Investments [Line Items]
Acquisition Date	[4]		Jun. 28, 2019
Par Amount	[4]		$ 56,483
Cost	[4]		27
Fair Value	[4]		$ 9
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% SLR-AMI Topco Blocker, LLC Industry Internet & Catalog Retail Acquisition Date 6/16/2023
Schedule of Investments [Line Items]
Acquisition Date	[4],[5],[6]		Jun. 16, 2023
Cost	[4],[5],[6]		$ 21,187
Fair Value	[4],[5],[6]		$ 13,958
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Vapotherm, Inc Industry Health Care Equipment & Supplies Acquisition Date 2/18/2022
Schedule of Investments [Line Items]
Acquisition Date	[4]		Feb. 18, 2022
Par Amount	[4]		$ 27,426
Cost	[4]		114
Fair Value	[4]		$ 1
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% AMF Levered II, LLC Industry Diversified Financial Services Spread above Index S+705 Floor 1.00% Interest Rate 12.52% Acquisition Date 12/24/2021 Maturity Date 8/21/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		705%
Floor	[2]		1%
Interest Rate	[2],[3]		12.52%
Acquisition Date	[2]		Dec. 24, 2021
Maturity Date	[2]		Aug. 21, 2028
Par Amount	[2]		$ 12,660
Cost	[2]		12,469
Fair Value	[2]		$ 12,407
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% All State Ag Parts, LLC Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 11.61% Acquisition Date 9/1/2021 Maturity Date 9/1/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		600%
Floor	[2]		1%
Interest Rate	[2],[3]		11.61%
Acquisition Date	[2]		Sep. 01, 2021
Maturity Date	[2]		Sep. 01, 2026
Par Amount	[2]		$ 5,165
Cost	[2]		5,107
Fair Value	[2]		$ 5,165
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Arcutis Biotherapeutics, Inc Industry Pharmaceuticals Spread above Index S+745 Floor 0.10% Interest Rate 12.90% Acquisition Date 12/22/2021 Maturity Date 1/1/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2],[7]		745%
Floor	[2],[7]		0.10%
Interest Rate	[2],[3],[7]		12.90%
Acquisition Date	[2],[7]		Dec. 22, 2021
Maturity Date	[2],[7]		Jan. 01, 2027
Par Amount	[2],[7]		$ 24,520
Cost	[2],[7]		25,044
Fair Value	[2],[7]		$ 25,011
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Ardelyx, Inc Industry Pharmaceuticals Spread above Index S+795 Floor 1.00% Interest Rate 13.32% Acquisition Date 2/23/2022 Maturity Date 3/1/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2],[7]		795%
Floor	[2],[7]		1%
Interest Rate	[2],[3],[7]		13.32%
Acquisition Date	[2],[7]		Feb. 23, 2022
Maturity Date	[2],[7]		Mar. 01, 2027
Par Amount	[2],[7]		$ 6,035
Cost	[2],[7]		6,080
Fair Value	[2],[7]		$ 6,224
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% BayMark Health Services, Inc Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 10.61% Acquisition Date 6/29/2021 Maturity Date 6/11/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		500%
Floor	[2]		1%
Interest Rate	[2],[3]		10.61%
Acquisition Date	[2]		Jun. 29, 2021
Maturity Date	[2]		Jun. 11, 2027
Par Amount	[2]		$ 15,701
Cost	[2]		15,599
Fair Value	[2]		$ 15,701
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% BridgeBio Pharma, Inc Industry Biotechnology Interest Rate 9.00% Acquisition Date 11/17/2021 Maturity Date 11/17/2026
Schedule of Investments [Line Items]
Interest Rate	[2],[3],[7],[8]		9%
Acquisition Date	[2],[7]		Nov. 17, 2021
Maturity Date	[2],[7]		Nov. 17, 2026
Par Amount	[2],[7]		$ 14,691
Cost	[2],[7]		14,683
Fair Value	[2],[7]		$ 14,728
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% CC SAG Holdings Corp. (Spectrum Automotve) Industry Diversified Consumer Services Spread above Index S+575 Floor 0.75% Interest Rate 11.22% Acquisition Date 6/29/2021 Maturity Date 6/29/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		575%
Floor	[2]		0.75%
Interest Rate	[2],[3]		11.22%
Acquisition Date	[2]		Jun. 29, 2021
Maturity Date	[2]		Jun. 29, 2028
Par Amount	[2]		$ 12,545
Cost	[2]		12,391
Fair Value	[2]		$ 12,545
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Cerapedics, Inc Industry Biotechnology Spread above Index S+620 Floor 2.75% Interest Rate 11.55% Acquisition Date 12/27/2022 Maturity Date 1/1/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		620%
Floor	[2]		2.75%
Interest Rate	[2],[3]		11.55%
Acquisition Date	[2]		Dec. 27, 2022
Maturity Date	[2]		Jan. 01, 2028
Par Amount	[2]		$ 12,122
Cost	[2]		12,158
Fair Value	[2]		$ 12,122
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) Industry Trading Companies & Distributors Spread above Index S+475 Floor 1.00% Interest Rate 10.20% Acquisition Date 12/31/2019 Maturity Date 12/31/2025
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		475%
Floor	[2]		1%
Interest Rate	[2],[3]		10.20%
Acquisition Date	[2]		Dec. 31, 2019
Maturity Date	[2]		Dec. 31, 2025
Par Amount	[2]		$ 6,967
Cost	[2]		6,916
Fair Value	[2]		$ 6,967
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Enhanced Permanent Capital, LLC Industry Capital Markets Spread above Index S+700 Floor 1.00% Interest Rate 12.44% Acquisition Date 12/29/2020 Maturity Date 12/29/2025
Schedule of Investments [Line Items]
Spread above Index	[1],[2],[7]		700%
Floor	[2],[7]		1%
Interest Rate	[2],[3],[7]		12.44%
Acquisition Date	[2],[7]		Dec. 29, 2020
Maturity Date	[2],[7]		Dec. 29, 2025
Par Amount	[2],[7]		$ 9,062
Cost	[2],[7]		8,922
Fair Value	[2],[7]		$ 9,062
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Erie Construction Mid-west, LLC Industry Building Products Spread above Index S+475 Floor 1.00% Interest Rate 10.21% Acquisition Date 8/5/2021 Maturity Date 7/30/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		475%
Floor	[2]		1%
Interest Rate	[2],[3]		10.21%
Acquisition Date	[2]		Aug. 05, 2021
Maturity Date	[2]		Jul. 30, 2027
Par Amount	[2]		$ 10,797
Cost	[2]		10,676
Fair Value	[2]		$ 10,797
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Foundation Consumer Brands, LLC Industry Personal Products Spread above Index S+625 Floor 1.00% Interest Rate 11.97% Acquisition Date 2/12/2021 Maturity Date 2/12/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		625%
Floor	[2]		1%
Interest Rate	[2],[3]		11.79%
Acquisition Date	[2]		Feb. 12, 2021
Maturity Date	[2]		Feb. 12, 2027
Par Amount	[2]		$ 11,367
Cost	[2]		11,202
Fair Value	[2]		$ 11,367
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% GSM Acquisition Corp Industry Leisure Equipment & Products Spread above Index S+500 Floor 1.00% Interest Rate 10.47% Acquisition Date 4/20/2021 Maturity Date 11/16/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		500%
Floor	[2]		1%
Interest Rate	[2],[3]		10.47%
Acquisition Date	[2]		Apr. 20, 2021
Maturity Date	[2]		Nov. 16, 2026
Par Amount	[2]		$ 13,928
Cost	[2]		13,846
Fair Value	[2]		$ 13,928
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% High Street Buyer, Inc Industry Insurance Spread above Index S+575 Floor 0.75% Interest Rate 11.00% Acquisition Date 4/16/2021 Maturity Date 4/16/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		575%
Floor	[2]		0.75%
Interest Rate	[2],[3]		11%
Acquisition Date	[2]		Apr. 16, 2021
Maturity Date	[2]		Apr. 16, 2028
Par Amount	[2]		$ 11,976
Cost	[2]		11,803
Fair Value	[2]		$ 11,976
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Human Interest Inc Industry Internet Software & Services Spread above Index S+785 Floor 1.00% Interest Rate 13.19% Acquisition Date 6/30/2022 Maturity Date 7/1/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		785%
Floor	[2]		1%
Interest Rate	[2],[3]		13.19%
Acquisition Date	[2]		Jun. 30, 2022
Maturity Date	[2]		Jul. 01, 2027
Par Amount	[2]		$ 13,598
Cost	[2]		13,422
Fair Value	[2]		$ 13,598
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Kaseya, Inc Industry Software Spread above Index S+600 Floor 0.75% Interest Rate 11.38% Acquisition Date 6/22/2022 Maturity Date 6/23/2029
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		600%
Floor	[2]		0.75%
Interest Rate	[2],[3],[9]		11.38%
Acquisition Date	[2]		Jun. 22, 2022
Maturity Date	[2]		Jun. 23, 2029
Par Amount	[2]		$ 11,100
Cost	[2]		10,963
Fair Value	[2]		$ 11,100
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Kid Distro Holdings, LLC (Distro Kid) Industry Software Spread above Index S+550 Floor 1.00% Interest Rate 11.00% Acquisition Date 9/24/2021 Maturity Date 10/1/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		550%
Floor	[2]		1%
Interest Rate	[2],[3]		11%
Acquisition Date	[2]		Sep. 24, 2021
Maturity Date	[2]		Oct. 01, 2027
Par Amount	[2]		$ 12,330
Cost	[2]		12,164
Fair Value	[2]		$ 12,330
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Meditrina, Inc Industry Health Care Equipment & Supplies Spread above Index S+550 Floor 3.45% Interest Rate 10.85% Acquisition Date 12/20/2022 Maturity Date 12/1/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		550%
Floor	[2]		3.45%
Interest Rate	[2],[3]		10.85%
Acquisition Date	[2]		Dec. 20, 2022
Maturity Date	[2]		Dec. 01, 2027
Par Amount	[2]		$ 1,212
Cost	[2]		1,215
Fair Value	[2]		$ 1,224
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Nexus Intermediate III, LLC (Vortex) Industry Professional Services Spread above Index S+550 Floor 0.75% Interest Rate 11.36% Acquisition Date 12/13/2021 Maturity Date 12/6/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		550%
Floor	[2]		0.75%
Interest Rate	[2],[3]		11.36%
Acquisition Date	[2]		Dec. 13, 2021
Maturity Date	[2]		Dec. 06, 2027
Par Amount	[2]		$ 5,381
Cost	[2]		5,315
Fair Value	[2]		$ 5,381
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Orthopedic Care Partners Management,LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 12.11% Acquisition Date 8/17/2022 Maturity Date 5/16/2024
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		650%
Floor	[2]		1%
Interest Rate	[2],[3]		12.11%
Acquisition Date	[2]		Aug. 17, 2022
Maturity Date	[2]		May 16, 2024
Par Amount	[2]		$ 6,368
Cost	[2]		6,354
Fair Value	[2]		$ 6,368
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Outset Medical, Inc Industry Health Care Providers & Services Spread above Index S+515 Floor 2.27% Interest Rate 10.50% Acquisition Date 11/3/2022 Maturity Date 11/1/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2],[7]		515%
Floor	[2],[7]		2.75%
Interest Rate	[2],[3],[7]		10.50%
Acquisition Date	[2],[7]		Nov. 03, 2022
Maturity Date	[2],[7]		Nov. 01, 2027
Par Amount	[2],[7]		$ 16,518
Cost	[2],[7]		16,546
Fair Value	[2],[7]		$ 16,560
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Peter C. Foy & Associates Insurance Services, LLC Industry Insurance Spread above Index S+600 Floor 0.75% Interest Rate 11.47% Acquisition Date 10/29/2021 Maturity Date 11/1/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		600%
Floor	[2]		0.75%
Interest Rate	[2],[3]		11.47%
Acquisition Date	[2]		Oct. 29, 2021
Maturity Date	[2]		Nov. 01, 2028
Par Amount	[2]		$ 15,422
Cost	[2]		15,307
Fair Value	[2]		$ 15,113
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Pinnacle Treatment Centers, Inc Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.95% Acquisition Date 1/22/2020 Maturity Date 1/2/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		650%
Floor	[2]		1%
Interest Rate	[2],[3]		11.95%
Acquisition Date	[2]		Jan. 22, 2020
Maturity Date	[2]		Jan. 02, 2026
Par Amount	[2]		$ 8,254
Cost	[2]		8,180
Fair Value	[2]		$ 8,254
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Plastics Management, LLC Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 10.45% Acquisition Date 8/26/2021 Maturity Date 8/18/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		500%
Floor	[2]		1%
Interest Rate	[2],[3]		10.45%
Acquisition Date	[2]		Aug. 26, 2021
Maturity Date	[2]		Aug. 18, 2027
Par Amount	[2]		$ 15,058
Cost	[2]		14,912
Fair Value	[2]		$ 15,058
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% RQM+ Corp Industry Life Sciences Tools & Services Spread above Index S+575 Floor 1.00% Interest Rate 11.36% Acquisition Date 8/20/2021 Maturity Date 8/12/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		575%
Floor	[2]		1%
Interest Rate	[2],[3]		11.36%
Acquisition Date	[2]		Aug. 20, 2021
Maturity Date	[2]		Aug. 12, 2026
Par Amount	[2]		$ 15,522
Cost	[2]		15,388
Fair Value	[2]		$ 15,522
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% RxSense Holdings LLC Industry Diversified Consumer Services Spread above Index S+500 Floor 1.00% Interest Rate 10.48% Acquisition Date 3/17/2020 Maturity Date 3/13/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		500%
Floor	[2]		1%
Interest Rate	[2],[3]		10.48%
Acquisition Date	[2]		Mar. 17, 2020
Maturity Date	[2]		Mar. 13, 2026
Par Amount	[2]		$ 14,486
Cost	[2]		14,380
Fair Value	[2]		$ 14,486
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Southern Orthodontic Partners Management, LLC Industry Health Care Providers & Services Spread above Index S+625 Floor 1.00% Interest Rate 11.86% Acquisition Date 6/3/2022 Maturity Date 1/27/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		625%
Floor	[2]		1%
Interest Rate	[2],[3]		11.86%
Acquisition Date	[2]		Jun. 03, 2022
Maturity Date	[2]		Jan. 27, 2026
Par Amount	[2]		$ 4,475
Cost	[2]		4,443
Fair Value	[2]		$ 4,475
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% SunMed Group Holdings, LLC Industry Health Care Providers & Services Spread above Index S+550 Floor 0.75% Interest Rate 10.96% Acquisition Date 6/16/2021 Maturity Date 6/16/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		550%
Floor	[2]		0.75%
Interest Rate	[2],[3]		10.96%
Acquisition Date	[2]		Jun. 16, 2021
Maturity Date	[2]		Jun. 16, 2028
Par Amount	[2]		$ 7,604
Cost	[2]		7,512
Fair Value	[2]		$ 7,604
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% TAUC Management, LLC Industry Health Care Providers & Services Spread above Index P+450 Floor 1.00% Interest Rate 13.00% Acquisition Date 2/12/2021 Maturity Date 2/12/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		450%
Floor	[2]		1%
Interest Rate	[2],[3]		13%
Acquisition Date	[2]		Feb. 12, 2021
Maturity Date	[2]		Feb. 12, 2027
Par Amount	[2]		$ 9,003
Cost	[2]		8,925
Fair Value	[2]		$ 8,373
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Tilley Distribution, Inc Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 11.50% Acquisition Date 12/8/2021 Maturity Date 13/31/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		600%
Floor	[2]		1%
Interest Rate	[2],[3]		11.50%
Acquisition Date	[2]		Dec. 08, 2021
Maturity Date	[2]		Dec. 31, 2026
Par Amount	[2]		$ 12,331
Cost	[2]		12,233
Fair Value	[2]		$ 12,331
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Transportation Insight, LLC Industry Road & Rail Spread above Index S+450 Floor 1.00% Interest Rate 9.98% Acquisition Date 10/27/2021 Maturity Date 12/18/2024
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		450%
Floor	[2]		1%
Interest Rate	[2],[3]		9.98%
Acquisition Date	[2]		Oct. 27, 2021
Maturity Date	[2]		Dec. 18, 2024
Par Amount	[2]		$ 6,021
Cost	[2]		5,984
Fair Value	[2]		$ 5,780
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Ultimate Baked Goods Midco LLC (Rise Baking) Industry Packaged Foods & Meats Spread above Index S+625 Floor 1.00% Interest Rate 11.71% Acquisition Date 8/12/2021 Maturity Date 8/13/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		625%
Floor	[2]		1%
Interest Rate	[2],[3]		11.71%
Acquisition Date	[2]		Aug. 12, 2021
Maturity Date	[2]		Aug. 13, 2027
Par Amount	[2]		$ 7,554
Cost	[2]		7,430
Fair Value	[2]		$ 7,479
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Vapotherm, Inc Industry Health Care Equipment & Supplies Spread above Index S+930 Floor 1.00% Interest Rate 14.75% Acquisition Date 2/18/2022 Maturity Date 2/1/2027
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		930%
Floor	[2]		1%
Interest Rate	[2],[3],[10]		14.75%
Acquisition Date	[2]		Feb. 18, 2022
Maturity Date	[2]		Feb. 01, 2027
Par Amount	[2]		$ 13,196
Cost	[2]		13,401
Fair Value	[2]		$ 13,394
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Vessco Midco Holdings, LLC Industry Water Utilities Spread above Index S+450 Floor 1.00% Interest Rate 9.96% Acquisition Date 9/3/2021 Maturity Date 11/2/2026
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		450%
Floor	[2]		1%
Interest Rate	[2],[3]		9.96%
Acquisition Date	[2]		Sep. 03, 2021
Maturity Date	[2]		Nov. 02, 2026
Par Amount	[2]		$ 5,513
Cost	[2]		5,471
Fair Value	[2]		$ 5,513
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% iCIMS, Inc Industry Software Spread above Index S+725 Floor 0.75% Interest Rate 12.62% Acquisition Date 8/18/2022 Maturity Date 8/18/2028
Schedule of Investments [Line Items]
Spread above Index	[1],[2]		725%
Floor	[2]		0.75%
Interest Rate	[2],[3],[11]		12.62%
Acquisition Date	[2]		Aug. 18, 2022
Maturity Date	[2]		Aug. 18, 2028
Par Amount	[2]		$ 14,195
Cost	[2]		13,996
Fair Value	[2]		$ 14,195
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1%
Schedule of Investments [Line Items]
Cost		328,867
Fair Value		$ 330,577
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% AMF Levered II, LLC Industry Diversified Financial Services Spread above Index S+705 Floor 1.00% Interest Rate 12.02% Acquisition Date 12/24/2021 Maturity Date 8/21/2028
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	705%
Floor	[13]	1%
Interest Rate	[13],[14]	12.02%
Acquisition Date	[13]	Dec. 24, 2021
Maturity Date	[13]	Aug. 21, 2028
Par Amount	[13]	$ 12,660
Cost	[13]	12,578
Fair Value	[13]	$ 12,660
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% All States Ag Parts, LLC Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 10.96% Acquisition Date 9/1/2021 Maturity Date 9/1/2026
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	600%
Floor	[13]	1%
Interest Rate	[13],[14]	10.96%
Acquisition Date	[13]	Sep. 01, 2021
Maturity Date	[13]	Sep. 01, 2026
Par Amount	[13]	$ 5,126
Cost	[13]	5,083
Fair Value	[13]	$ 5,126
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Arcutis Biotherapeutics, Inc Industry Pharmaceuticals Spread above Index S+595 Floor 2.50% Interest Rate 11.12% Acquisition Date 12/22/2021 Maturity Date 8/1/2029
Schedule of Investments [Line Items]
Spread above Index	[12],[13],[15]	595%
Floor	[13],[15]	2.50%
Interest Rate	[13],[14],[15]	11.12%
Acquisition Date	[13],[15]	Dec. 22, 2021
Maturity Date	[13],[15]	Aug. 01, 2029
Par Amount	[13],[15]	$ 24,520
Cost	[13],[15]	25,316
Fair Value	[13],[15]	$ 25,922
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Ardelyx, Inc Industry Pharmaceuticals Spread above Index S+795 Floor 1.00% Interest Rate 13.14% Acquisition Date 2/23/2022 Maturity Date 3/1/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13],[15]	795%
Floor	[13],[15]	1%
Interest Rate	[13],[14],[15]	13.14%
Acquisition Date	[13],[15]	Feb. 23, 2022
Maturity Date	[13],[15]	Mar. 01, 2027
Par Amount	[13],[15]	$ 6,035
Cost	[13],[15]	6,140
Fair Value	[13],[15]	$ 6,216
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% BayMark Health Services, Inc Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 9.87% Acquisition Date 6/29/2021 Maturity Date 6/11/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	500%
Floor	[13]	1%
Interest Rate	[13],[14]	9.87%
Acquisition Date	[13]	Jun. 29, 2021
Maturity Date	[13]	Jun. 11, 2027
Par Amount	[13]	$ 15,580
Cost	[13]	15,500
Fair Value	[13]	$ 15,580
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% CC SAG Holdings Corp. (Spectrum Automotve) Industry Diversified Consumer Services Spread above Index S+575 Floor 0.75% Interest Rate 9.85% Acquisition Date 6/29/2021 Maturity Date 6/29/2028
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	525%
Floor	[13]	0.75%
Interest Rate	[13],[14]	9.85%
Acquisition Date	[13]	Jun. 29, 2021
Maturity Date	[13]	Jun. 29, 2028
Par Amount	[13]	$ 12,449
Cost	[13]	12,318
Fair Value	[13]	$ 12,449
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Cerapedics, Inc Industry Biotechnology Spread above Index S+620 Floor 2.75% Interest Rate 11.53% Acquisition Date 12/27/2022 Maturity Date 1/1/2028
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	620%
Floor	[13]	2.75%
Interest Rate	[13],[14]	11.37%
Acquisition Date	[13]	Dec. 27, 2022
Maturity Date	[13]	Jan. 01, 2028
Par Amount	[13]	$ 12,122
Cost	[13]	12,217
Fair Value	[13]	$ 12,416
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) Industry Trading Companies & Distributors Spread above Index S+475 Floor 1.00% Interest Rate 9.45% Acquisition Date 12/31/2019 Maturity Date 12/31/2025
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	475%
Floor	[13]	1%
Interest Rate	[13],[14]	9.45%
Acquisition Date	[13]	Dec. 31, 2019
Maturity Date	[13]	Dec. 31, 2025
Par Amount	[13]	$ 7,134
Cost	[13]	7,103
Fair Value	[13]	$ 7,134
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Enhanced Permanent Capital, LLC Industry Capital Markets Spread above Index S+700 Floor 1.00% Interest Rate 12.44% Acquisition Date 12/29/2020 Maturity Date 12/29/2025
Schedule of Investments [Line Items]
Spread above Index	[12],[13],[15]	700%
Floor	[13],[15]	1%
Interest Rate	[13],[14],[15]	12.44%
Acquisition Date	[13],[15]	Dec. 29, 2020
Maturity Date	[13],[15]	Dec. 29, 2025
Par Amount	[13],[15]	$ 9,501
Cost	[13],[15]	9,406
Fair Value	[13],[15]	$ 9,501
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Erie Construction Mid-west, LLC Industry Building Products Spread above Index S+475 Floor 1.00% Interest Rate 10.08% Acquisition Date 8/5/2021 Maturity Date 7/30/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	475%
Floor	[13]	1%
Interest Rate	[13],[14]	10.08%
Acquisition Date	[13]	Aug. 05, 2021
Maturity Date	[13]	Jul. 30, 2027
Par Amount	[13]	$ 10,359
Cost	[13]	10,266
Fair Value	[13]	$ 10,359
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Fertility (ITC) Investment Holdco, LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.74% Acquisition Date 1/4/2023 Maturity Date 1/3/2029
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	650%
Floor	[13]	1%
Interest Rate	[13],[14]	11.74%
Acquisition Date	[13]	Jan. 04, 2023
Maturity Date	[13]	Jan. 03, 2029
Par Amount	[13]	$ 10,200
Cost	[13]	9,962
Fair Value	[13]	$ 10,200
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Foundation Consumer Brands, LLC Industry Personal Products Spread above Index S+625 Floor 1.00% Interest Rate 11.50% Acquisition Date 02/12/2021 Maturity Date 02/12/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	625%
Floor	[13]	1%
Interest Rate	[13],[14]	11.50%
Acquisition Date	[13]	Feb. 12, 2021
Maturity Date	[13]	Feb. 12, 2027
Par Amount	[13]	$ 10,885
Cost	[13]	10,762
Fair Value	[13]	$ 10,885
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% High Street Buyer, Inc. Industry Insurance Spread above Index S+525 Floor 0.75% Interest Rate 9.85% Acquisition Date 04/16/2021 Maturity Date 04/16/2028
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	525%
Floor	[13]	0.75%
Interest Rate	[13],[14]	9.85%
Acquisition Date	[13]	Apr. 16, 2021
Maturity Date	[13]	Apr. 16, 2028
Par Amount	[13]	$ 11,885
Cost	[13]	11,739
Fair Value	[13]	$ 11,885
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Human Interest Inc. Industry Internet Software & Services Spread above Index S+735 Floor 1.00% Interest Rate 12.55% Acquisition Date 06/30/2022 Maturity Date 07/01/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	735%
Floor	[13]	1%
Interest Rate	[13],[14]	12.55%
Acquisition Date	[13]	Jun. 30, 2022
Maturity Date	[13]	Jul. 01, 2027
Par Amount	[13]	$ 13,598
Cost	[13]	13,513
Fair Value	[13]	$ 13,598
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Kaseya, Inc. Industry Software Spread above Index S+550 Floor 0.75% Interest Rate 10.75% Acquisition Date 06/22/2022 Maturity Date 06/23/2029
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	550%
Floor	[13]	0.75%
Interest Rate	[13],[14],[16]	10.75%
Acquisition Date	[13]	Jun. 22, 2022
Maturity Date	[13]	Jun. 23, 2029
Par Amount	[13]	$ 11,213
Cost	[13]	11,092
Fair Value	[13]	$ 11,213
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Meditrina, Inc. Industry Health Care Equipment & Supplies Spread above Index S+550 Floor 3.45% Interest Rate 10.67% Acquisition Date 12/20/2022 Maturity Date 12/01/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	550%
Floor	[13]	3.45%
Interest Rate	[13],[14]	10.67%
Acquisition Date	[13]	Dec. 20, 2022
Maturity Date	[13]	Dec. 01, 2027
Par Amount	[13]	$ 1,818
Cost	[13]	1,833
Fair Value	[13]	$ 1,836
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Nexus Intermediate III, LLC (Vortex) Industry Professional Services Spread above Index S+550 Floor 0.75% Interest Rate 10.71% Acquisition Date 12/13/2021 Maturity Date 12/06/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	550%
Floor	[13]	0.75%
Interest Rate	[13],[14]	10.71%
Acquisition Date	[13]	Dec. 13, 2021
Maturity Date	[13]	Dec. 06, 2027
Par Amount	[13]	$ 5,336
Cost	[13]	5,282
Fair Value	[13]	$ 5,243
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Orthopedic Care Partners Management, LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.46% Acquisition Date 08/17/2022 Maturity Date 11/15/2024
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	650%
Floor	[13]	1%
Interest Rate	[13],[14]	11.46%
Acquisition Date	[13]	Aug. 17, 2022
Maturity Date	[13]	Nov. 15, 2024
Par Amount	[13]	$ 6,318
Cost	[13]	6,314
Fair Value	[13]	$ 6,318
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Outset Medical, Inc. Industry Health Care Equipment & Supplies Spread above Index S+515 Floor 2.75% Interest Rate 10.32% Acquisition Date 11/03/2022 Maturity Date 11/01/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	515%
Floor	[13]	2.75%
Interest Rate	[13],[14]	10.32%
Acquisition Date	[13]	Nov. 03, 2022
Maturity Date	[13]	Nov. 01, 2027
Par Amount	[13]	$ 16,518
Cost	[13]	16,691
Fair Value	[13]	$ 17,468
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Peter C. Foy & Associates Insurance Services, LLC Industry Insurance Spread above Index S+550 Floor 0.75% Interest Rate 10.59% Acquisition Date 10/29/2021 Maturity Date 11/01/2028
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	550%
Floor	[13]	0.75%
Interest Rate	[13],[14]	10.59%
Acquisition Date	[13]	Oct. 29, 2021
Maturity Date	[13]	Nov. 01, 2028
Par Amount	[13]	$ 15,304
Cost	[13]	15,205
Fair Value	[13]	$ 15,304
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Plastic Management, LLC Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 9.70% Acquisition Date 08/26/2021 Maturity Date 08/18/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	500%
Floor	[13]	1%
Interest Rate	[13],[14]	9.70%
Acquisition Date	[13]	Aug. 26, 2021
Maturity Date	[13]	Aug. 18, 2027
Par Amount	[13]	$ 14,942
Cost	[13]	14,825
Fair Value	[13]	$ 14,942
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% RQM+ Corp. Industry Life Sciences Tools & Services Spread above Index S+575 Floor 1.00% Interest Rate 10.62% Acquisition Date 08/20/2021 Maturity Date 08/12/2026
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	575%
Floor	[13]	1%
Interest Rate	[13],[14]	10.62%
Acquisition Date	[13]	Aug. 20, 2021
Maturity Date	[13]	Aug. 12, 2026
Par Amount	[13]	$ 15,403
Cost	[13]	15,306
Fair Value	[13]	$ 14,787
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% RxSense Holdings LLC Industry Diversified Consumer Services Spread above Index S+500 Floor 1.00% Interest Rate 10.35% Acquisition Date 03/17/2020 Maturity Date 03/13/2026
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	500%
Floor	[13]	1%
Interest Rate	[13],[14]	10.35%
Acquisition Date	[13]	Mar. 17, 2020
Maturity Date	[13]	Mar. 13, 2026
Par Amount	[13]	$ 14,373
Cost	[13]	14,302
Fair Value	[13]	$ 14,373
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Southern Orthodontic Partners Management, LLC Industry Health Care Providers & Services Spread above Index S+550 Floor 1.00% Interest Rate 10.10% Acquisition Date 06/03/2022 Maturity Date 07/27/2026
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	550%
Floor	[13]	1%
Interest Rate	[13],[14]	10.10%
Acquisition Date	[13]	Jun. 03, 2022
Maturity Date	[13]	Jul. 27, 2026
Par Amount	[13]	$ 4,441
Cost	[13]	4,416
Fair Value	[13]	$ 4,441
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% SunMed Group Holdings, LLC Industry Health Care Equipment & Supplies Spread above Index S+550 Floor 0.75% Interest Rate 10.46% Acquisition Date 06/16/2021 Maturity Date 06/16/2028
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	550%
Floor	[13]	0.75%
Interest Rate	[13],[14]	10.46%
Acquisition Date	[13]	Jun. 16, 2021
Maturity Date	[13]	Jun. 16, 2028
Par Amount	[13]	$ 8,061
Cost	[13]	7,982
Fair Value	[13]	$ 8,061
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% TAUC Management, LLC Industry Health Care Providers & Services Spread above Index S+700 Floor 1.00% Interest Rate 11.75% Acquisition Date 02/12/2021 Maturity Date 02/12/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13],[17]	700%
Floor	[13]	1%
Interest Rate	[13],[14]	11.75%
Acquisition Date	[13]	Feb. 12, 2021
Maturity Date	[13]	Feb. 12, 2027
Par Amount	[13]	$ 9,126
Cost	[13]	9,065
Fair Value	[13]	$ 8,213
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Tilley Distribution, Inc. Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 10.75% Acquisition Date 12/08/2021 Maturity Date 12/31/2026
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	600%
Floor	[13]	1%
Interest Rate	[13],[14]	10.75%
Acquisition Date	[13]	Dec. 08, 2021
Maturity Date	[13]	Dec. 31, 2026
Par Amount	[13]	$ 11,899
Cost	[13]	11,826
Fair Value	[13]	$ 11,661
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Transportation Insight, LLC Industry Road & Rail Spread above Index S+550 Floor 1.00% Interest Rate 9.93% Acquisition Date 10/27/2021 Maturity Date 12/18/2024
Schedule of Investments [Line Items]
Spread above Index	[12],[13],[18]	550%
Floor	[13]	1%
Interest Rate	[13],[14]	9.93%
Acquisition Date	[13]	Oct. 27, 2021
Maturity Date	[13]	Dec. 18, 2024
Par Amount	[13]	$ 5,762
Cost	[13]	5,754
Fair Value	[13]	$ 5,416
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Ultimate Baked Goods Midco LLC (Rise Baking) Industry Packaged Foods & Meats Spread above Index S+625 Floor 1.00% Interest Rate 11.34% Acquisition Date 08/12/2021 Maturity Date 08/13/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	625%
Floor	[13]	1%
Interest Rate	[13],[14]	11.34%
Acquisition Date	[13]	Aug. 12, 2021
Maturity Date	[13]	Aug. 13, 2027
Par Amount	[13]	$ 7,824
Cost	[13]	7,723
Fair Value	[13]	$ 7,824
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Vapotherm, Inc. Industry Health Care Equipment & Supplies Spread above Index S+600 Floor 4.50% Interest Rate 10.97% Acquisition Date 02/18/2022 Maturity Date 09/20/2027
Schedule of Investments [Line Items]
Spread above Index	[12],[19]	600%
Floor	[19]	4.50%
Interest Rate	[14],[19]	10.97%
Acquisition Date	[19]	Feb. 18, 2022
Maturity Date	[19]	Sep. 20, 2027
Par Amount	[19]	$ 4,828
Cost	[19]	4,949
Fair Value	[19]	$ 4,975
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% iCIMS, Inc. Industry Software Spread above Index S+725 Floor 0.75% Interest Rate 10.67% Acquisition Date 08/18/2022 Maturity Date 08/18/2028
Schedule of Investments [Line Items]
Spread above Index	[12],[13]	725%
Floor	[13]	0.75%
Interest Rate	[13],[14],[20]	10.67%
Acquisition Date	[13]	Aug. 18, 2022
Maturity Date	[13]	Aug. 18, 2028
Par Amount	[13]	$ 14,571
Cost	[13]	14,399
Fair Value	[13]	14,571
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants
Schedule of Investments [Line Items]
Cost		21,383
Fair Value		$ 13,765
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Assertio Holdings, Inc. Common Stock Industry Pharmaceuticals Acquisition Date 7/31/2023
Schedule of Investments [Line Items]
Acquisition Date	[4],[21]		Jul. 31, 2023
Par Amount	[4],[21]		$ 4,230
Cost	[4],[21]		17
Fair Value	[4],[21]		$ 5
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Meditrina, Inc. Warrants Industry Health Care Equipment & Supplies Acquisition Date 12/20/2022
Schedule of Investments [Line Items]
Acquisition Date	[4]		Dec. 20, 2022
Par Amount	[4]		$ 10,572
Cost	[4]		8
Fair Value	[4]		$ 7
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Senseonics Holdings, Inc Common Stock Industry Health Care Equipment & Supplies Acquisition Date 7/25/2019
Schedule of Investments [Line Items]
Acquisition Date	[4],[7],[21]		Jul. 25, 2019
Par Amount	[4],[7],[21]		$ 79,501
Cost	[4],[7],[21]		23
Fair Value	[4],[7],[21]		45
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Assertio Holdings, Inc. Common Stock Industry Pharmaceuticals Acquisition Date 7/31/2023
Schedule of Investments [Line Items]
Acquisition Date	[22]	Jul. 31, 2023
Par Amount	[22]	$ 4,230
Cost	[22]	17
Fair Value	[22]	$ 5
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Centrexion Therapeutics, Inc. Warrants Industry Pharmaceuticals Acquisition Date 6/28/2019
Schedule of Investments [Line Items]
Acquisition Date	[23]	Jun. 28, 2019
Par Amount	[23]	$ 56,483
Cost	[23]	27
Fair Value	[23]	$ 6
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Meditrina, Inc. Warrants Industry Health Care Equipment & Supplies Acquisition Date 12/20/2022
Schedule of Investments [Line Items]
Acquisition Date	[23]	Dec. 20, 2022
Par Amount	[23]	$ 15,858
Cost	[23]	12
Fair Value	[23]	$ 10
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% SLR-AMI Topco Blocker, LLC Industry Internet & Catalog Retail Acquisition Date 6/16/2023
Schedule of Investments [Line Items]
Acquisition Date	[19],[24]	Jun. 16, 2023
Cost	[19],[24]	$ 21,187
Fair Value	[19],[24]	$ 13,492
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Senseonics Holdings, Inc Common Stock Industry Health Care Equipment & Supplies Acquisition Date 7/25/2019
Schedule of Investments [Line Items]
Acquisition Date	[22]	Jul. 25, 2019
Par Amount	[22]	$ 79,501
Cost	[22]	23
Fair Value	[22]	$ 28
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Veronica Holdings, LLC Industry Health Care Equipment & Supplies Acquisition Date 2/18/2022
Schedule of Investments [Line Items]
Acquisition Date	[19]	Sep. 20, 2024
Par Amount	[19]	$ 102,711
Cost	[19]	117
Fair Value	[19]	224
Investment, Identifier [Axis]: Liabilities in Excess of Other
Schedule of Investments [Line Items]
Fair Value			(152,267)
Investment, Identifier [Axis]: Liabilities in Excess of Other Assets - (85.5%)
Schedule of Investments [Line Items]
Fair Value		(163,332)
Investment, Identifier [Axis]: Net Assets — 100.0%
Schedule of Investments [Line Items]
Fair Value		191,008	268,301
Investment, Identifier [Axis]: Oldco AI, LLC (f/k/a Amerimark)
Schedule of Investments [Line Items]
Fair Value			0	8,243
Investment, Identifier [Axis]: Oldco AI, LLC (f/k/a Amerimark) One
Schedule of Investments [Line Items]
Fair Value			0	0
Investment, Identifier [Axis]: Preferred Equity — 5.2%
Schedule of Investments [Line Items]
Cost		9,491
Fair Value		$ 9,998
Investment, Identifier [Axis]: Preferred Equity — 5.2% Veronica Holdings, LLC (Vapotherm) Industry Health Care Equipment & Supplies Interest Rate 9.00% PIK Acquisition Date 9/20/2024
Schedule of Investments [Line Items]
Interest rate, paid in kind	[19]	9%
Acquisition Date	[19]	Sep. 20, 2024
Par Amount	[19]	$ 4,573,737
Cost	[19]	9,491
Fair Value	[19]	9,998
Investment, Identifier [Axis]: SLR-AMI Topco Blocker, LLC
Schedule of Investments [Line Items]
Fair Value		13,492	13,958	$ 6,170
Investment, Identifier [Axis]: Total Bank Debt/Senior Secured Loans
Schedule of Investments [Line Items]
Cost			404,387
Fair Value			406,543
Investment, Identifier [Axis]: Total Common Equity/Equity
Schedule of Investments [Line Items]
Cost			21,376
Fair Value			14,025
Investment, Identifier [Axis]: Total Investments — 185.5%
Schedule of Investments [Line Items]
Cost	[25]	359,741
Fair Value	[25]	354,340
Investment, Identifier [Axis]: Total Investments(10) — 156.8%
Schedule of Investments [Line Items]
Cost	[26]		425,763
Fair Value	[26]		420,568
Investment, Identifier [Axis]: Vapotherm, Inc.
Schedule of Investments [Line Items]
Fair Value		4,975	0
Investment, Identifier [Axis]: Veronica Holdings, LLC (Common Equity)
Schedule of Investments [Line Items]
Fair Value		224	0
Investment, Identifier [Axis]: Veronica Holdings, LLC (Preferred Equity)
Schedule of Investments [Line Items]
Fair Value		$ 9,998	$ 0

[1] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC. Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Floating rate debt investments typically bear interest at a rate determined by reference to either the Secured Overnight Financing Rate or the prime index rate, and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current interest rate in effect as of December 31, 2023. Non-income producing security. Denotes investments in which the Company is an “Affiliated Person” but does not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the period June 16, 2023 (date at which the Company became an “Affiliated Person”) through December 31, 2023 in these affiliated investments are as follows: Through this entity and other intermediate entities, the Company owns approximately 6.5 % of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former AmeriMark Interactive, LLC. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If the Company fails to invest a sufficient portion of its assets in qualifying assets, it could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2023, on a fair value basis, non-qualifying assets in the Company’s portfolio represented 15.4% of the total assets of the Company. BridgeBio Pharma, Inc. may elect to defer up to 3.00 % of the coupon as PIK. Kaseya, Inc. may elect to defer up to 2.50 % of the coupon as PIK. Vapotherm, Inc. may elect to defer up to 8.00 % of the coupon as PIK. iCIMS, Inc. may elect to defer up to 3.875 % of the coupon as PIK. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to SOFR or PRIME rate floor. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC (the “SPV”). Such investments are pledged as collateral under the DB Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Floating rate debt investments typically bear interest at a rate determined by reference to either the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment, we have provided the current interest rate in effect as of September 30, 2024. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”). If the Company fails to invest a sufficient portion of its assets in qualifying assets, it could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2024, on a fair value basis, non-qualifying assets in the Company ’s portfolio represented 9.9% of the total assets of the Company. Kaseya, Inc. may elect to defer up to 2.50 % of the coupon as PIK. Spread is S+ 600 Cash/ 1.00 % PIK Spread is S+450 Cash / 1.00% PIK Denotes investments in which the Company is an “Affiliated Person” but does not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2024 in these affiliated investments are as follows: Name of Issuer Fair Value at Gross Gross Realized Gain Change in Unrealized Fair Value at Interest/Dividend SLR-AMI Topco Blocker, LLC $ 13,958 $ — $ — $ — $ ( 466 ) $ 13,492 $ — Vapotherm, Inc. — 4,947 — — 26 4,975 18 Veronica Holdings, LLC (Preferred Equity) — 9,487 — — 507 9,998 32 Veronica Holdings, LLC (Common Equity) — 118 — — 106 224 — $ 13,958 $ 14,552 $ — $ — $ 173 $ 28,689 $ 50 iCIMS, Inc. may elect to defer up to 3.875 % of the coupon as paid in kind (“PIK”) Denotes a Level 1 investment. Denotes a Level 1 investment. Non-income producing security. Through this entity and other intermediate entities, the Company owns approximately 5.0 % of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former AmeriMark Interactive, LLC. Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 8,864 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 4,240 and $ 13,104 , respectively, based on a tax cost of $ 363,204 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 8,658 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 3,286 and $ 11,944 , respectively, based on a tax cost of $ 429,226 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments 1	Sep. 30, 2024	Dec. 31, 2023
Investment, Identifier [Axis]: Biotechnology
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	3.50%	6.40%
Investment, Identifier [Axis]: Building Products
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	2.90%	2.60%
Investment, Identifier [Axis]: Capital Markets
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	2.70%	2.20%
Investment, Identifier [Axis]: Diversified Consumer Services
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	7.60%	6.40%
Investment, Identifier [Axis]: Diversified Financial Services
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	3.60%	3%
Investment, Identifier [Axis]: Health Care Equipment & Supplies
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	12%	10.50%
Investment, Identifier [Axis]: Health Care Providers & Services
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	16.80%	16.30%
Investment, Identifier [Axis]: Health Care Technology
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value		0.40%
Investment, Identifier [Axis]: Insurance
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	7.70%	6.40%
Investment, Identifier [Axis]: Internet & Catalog Retail
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	3.80%	3.30%
Investment, Identifier [Axis]: Internet Software & Services
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	3.80%	3.20%
Investment, Identifier [Axis]: Leisure Equipment & Products
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value		3.30%
Investment, Identifier [Axis]: Life Sciences Tools & Services
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	4.20%	3.70%
Investment, Identifier [Axis]: Packaged Foods & Meats
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	2.20%	1.80%
Investment, Identifier [Axis]: Personal Products
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	3.10%	2.70%
Investment, Identifier [Axis]: Pharmaceuticals
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	9.10%	8.90%
Investment, Identifier [Axis]: Professional Services
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	1.50%	1.30%
Investment, Identifier [Axis]: Road and Rail
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	1.50%	1.40%
Investment, Identifier [Axis]: Software
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	7.30%	8.90%
Investment, Identifier [Axis]: Specialty Retail
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value		0.20%
Investment, Identifier [Axis]: Total Investments
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	100%	100%
Investment, Identifier [Axis]: Trading Companies & Distributors
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value	6.70%	5.80%
Investment, Identifier [Axis]: Water Utilities
Schedule of Investments [Line Items]
Percentage Of Total Investments At Fair Value		1.30%

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Parethetical) - USD ($) $ in Thousands		9 Months Ended	12 Months Ended
		Sep. 30, 2024	Dec. 31, 2023	Jun. 16, 2023
Schedule of Investments [Line Items]
Investment, Tax Basis, Unrealized Gain (Loss)		$ 8,864	$ 8,658
Investment, Tax Basis, Unrealized Gain		4,240	3,286
Investment, Tax Basis, Unrealized Loss		13,104	11,944
Investment, Tax Basis, Cost		363,204	429,226
Investment Owned, Fair Value		$ 28,689	13,958	$ 14,413
Spread above Index		600%
Investment, Interest Rate, Paid in Kind		1%
Gross Additions		$ 14,552	16,126
Gross Reductions		0	(16,126)
Realized Gain (Loss)		0	0
Change in Unrealized Gain (Loss)		173	(455)
Interest/Dividend Income		$ 50	$ 171
BridgeBio Pharma, Inc.
Schedule of Investments [Line Items]
Rate Of Coupon As PIK			3%
iCIMS, Inc
Schedule of Investments [Line Items]
Rate Of Coupon As PIK		3.875%	3.875%
Vapotherm, Inc.
Schedule of Investments [Line Items]
Rate Of Coupon As PIK			8%
ASC Holdco LLC
Schedule of Investments [Line Items]
Investment Company Percentage Of Ownership		5%	6.50%
Kaseya, Inc. [Member]
Schedule of Investments [Line Items]
Rate Of Coupon As PIK		2.50%	2.50%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Alimera Sciences, Inc Industry Pharmaceuticals Spread above Index S+515 Floor 4.60% Interest Rate 10.50% Acquisition Date 12/31/2019 Maturity Date 5/1/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 6,080
Spread above Index	[1],[2]		515%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Basic Fun, Inc Industry Specialty Retail Spread above Index S+650 Floor 1.00% Interest Rate 12.14% Acquisition Date 10/30/2020 Maturity Date 7/2/2024
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 960
Spread above Index	[1],[2]		650%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Fertility (ITC) Investment Holdco, LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.97% Acquisition Date 1/4/2023 Maturity Date 1/3/2029
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 10,278
Spread above Index	[1],[2]		650%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Glooko, Inn Industry Health Care Technology Spread above Index S+790 Floor 0.10% Interest Rate 13.35% Acquisition Date 9/30/2021 Maturity Date 10/1/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 1,849
Spread above Index	[1],[2]		790%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Neuronetics, Inc Industry Health Care Equipment & Supplies Spread above Index S+565 Floor 3.95% Interest Rate 11.00% Acquisition Date 3/2/2020 Maturity Date 3/29/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 5,238
Spread above Index	[1],[2]		565%
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Centrexion Therapeutics, Inc. Warrants Industry Pharmaceuticals Acquisition Date 6/28/2019
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[3]		$ 9
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% SLR-AMI Topco Blocker, LLC Industry Internet & Catalog Retail Acquisition Date 6/16/2023
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[3],[4],[5]		13,958
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Vapotherm, Inc Industry Health Care Equipment & Supplies Acquisition Date 2/18/2022
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[3]		1
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% AMF Levered II, LLC Industry Diversified Financial Services Spread above Index S+705 Floor 1.00% Interest Rate 12.52% Acquisition Date 12/24/2021 Maturity Date 8/21/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 12,407
Spread above Index	[1],[2]		705%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% All State Ag Parts, LLC Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 11.61% Acquisition Date 9/1/2021 Maturity Date 9/1/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 5,165
Spread above Index	[1],[2]		600%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Arcutis Biotherapeutics, Inc Industry Pharmaceuticals Spread above Index S+745 Floor 0.10% Interest Rate 12.90% Acquisition Date 12/22/2021 Maturity Date 1/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1],[6]		$ 25,011
Spread above Index	[1],[2],[6]		745%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Ardelyx, Inc Industry Pharmaceuticals Spread above Index S+795 Floor 1.00% Interest Rate 13.32% Acquisition Date 2/23/2022 Maturity Date 3/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1],[6]		$ 6,224
Spread above Index	[1],[2],[6]		795%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% BayMark Health Services, Inc Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 10.61% Acquisition Date 6/29/2021 Maturity Date 6/11/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 15,701
Spread above Index	[1],[2]		500%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% BridgeBio Pharma, Inc Industry Biotechnology Interest Rate 9.00% Acquisition Date 11/17/2021 Maturity Date 11/17/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1],[6]		$ 14,728
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% CC SAG Holdings Corp. (Spectrum Automotve) Industry Diversified Consumer Services Spread above Index S+575 Floor 0.75% Interest Rate 11.22% Acquisition Date 6/29/2021 Maturity Date 6/29/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 12,545
Spread above Index	[1],[2]		575%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Cerapedics, Inc Industry Biotechnology Spread above Index S+620 Floor 2.75% Interest Rate 11.55% Acquisition Date 12/27/2022 Maturity Date 1/1/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 12,122
Spread above Index	[1],[2]		620%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) Industry Trading Companies & Distributors Spread above Index S+475 Floor 1.00% Interest Rate 10.20% Acquisition Date 12/31/2019 Maturity Date 12/31/2025
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 6,967
Spread above Index	[1],[2]		475%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Enhanced Permanent Capital, LLC Industry Capital Markets Spread above Index S+700 Floor 1.00% Interest Rate 12.44% Acquisition Date 12/29/2020 Maturity Date 12/29/2025
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1],[6]		$ 9,062
Spread above Index	[1],[2],[6]		700%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Erie Construction Mid-west, LLC Industry Building Products Spread above Index S+475 Floor 1.00% Interest Rate 10.21% Acquisition Date 8/5/2021 Maturity Date 7/30/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 10,797
Spread above Index	[1],[2]		475%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Foundation Consumer Brands, LLC Industry Personal Products Spread above Index S+625 Floor 1.00% Interest Rate 11.97% Acquisition Date 2/12/2021 Maturity Date 2/12/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 11,367
Spread above Index	[1],[2]		625%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% GSM Acquisition Corp Industry Leisure Equipment & Products Spread above Index S+500 Floor 1.00% Interest Rate 10.47% Acquisition Date 4/20/2021 Maturity Date 11/16/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 13,928
Spread above Index	[1],[2]		500%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% High Street Buyer, Inc Industry Insurance Spread above Index S+575 Floor 0.75% Interest Rate 11.00% Acquisition Date 4/16/2021 Maturity Date 4/16/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 11,976
Spread above Index	[1],[2]		575%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Human Interest Inc Industry Internet Software & Services Spread above Index S+785 Floor 1.00% Interest Rate 13.19% Acquisition Date 6/30/2022 Maturity Date 7/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 13,598
Spread above Index	[1],[2]		785%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Kaseya, Inc Industry Software Spread above Index S+600 Floor 0.75% Interest Rate 11.38% Acquisition Date 6/22/2022 Maturity Date 6/23/2029
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 11,100
Spread above Index	[1],[2]		600%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Kid Distro Holdings, LLC (Distro Kid) Industry Software Spread above Index S+550 Floor 1.00% Interest Rate 11.00% Acquisition Date 9/24/2021 Maturity Date 10/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 12,330
Spread above Index	[1],[2]		550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Meditrina, Inc Industry Health Care Equipment & Supplies Spread above Index S+550 Floor 3.45% Interest Rate 10.85% Acquisition Date 12/20/2022 Maturity Date 12/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 1,224
Spread above Index	[1],[2]		550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Nexus Intermediate III, LLC (Vortex) Industry Professional Services Spread above Index S+550 Floor 0.75% Interest Rate 11.36% Acquisition Date 12/13/2021 Maturity Date 12/6/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 5,381
Spread above Index	[1],[2]		550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Orthopedic Care Partners Management,LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 12.11% Acquisition Date 8/17/2022 Maturity Date 5/16/2024
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 6,368
Spread above Index	[1],[2]		650%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Outset Medical, Inc Industry Health Care Providers & Services Spread above Index S+515 Floor 2.27% Interest Rate 10.50% Acquisition Date 11/3/2022 Maturity Date 11/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1],[6]		$ 16,560
Spread above Index	[1],[2],[6]		515%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Peter C. Foy & Associates Insurance Services, LLC Industry Insurance Spread above Index S+600 Floor 0.75% Interest Rate 11.47% Acquisition Date 10/29/2021 Maturity Date 11/1/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 15,113
Spread above Index	[1],[2]		600%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Pinnacle Treatment Centers, Inc Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.95% Acquisition Date 1/22/2020 Maturity Date 1/2/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 8,254
Spread above Index	[1],[2]		650%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Plastics Management, LLC Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 10.45% Acquisition Date 8/26/2021 Maturity Date 8/18/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 15,058
Spread above Index	[1],[2]		500%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% RQM+ Corp Industry Life Sciences Tools & Services Spread above Index S+575 Floor 1.00% Interest Rate 11.36% Acquisition Date 8/20/2021 Maturity Date 8/12/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 15,522
Spread above Index	[1],[2]		575%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% RxSense Holdings LLC Industry Diversified Consumer Services Spread above Index S+500 Floor 1.00% Interest Rate 10.48% Acquisition Date 3/17/2020 Maturity Date 3/13/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 14,486
Spread above Index	[1],[2]		500%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Southern Orthodontic Partners Management, LLC Industry Health Care Providers & Services Spread above Index S+625 Floor 1.00% Interest Rate 11.86% Acquisition Date 6/3/2022 Maturity Date 1/27/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 4,475
Spread above Index	[1],[2]		625%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% SunMed Group Holdings, LLC Industry Health Care Providers & Services Spread above Index S+550 Floor 0.75% Interest Rate 10.96% Acquisition Date 6/16/2021 Maturity Date 6/16/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 7,604
Spread above Index	[1],[2]		550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% TAUC Management, LLC Industry Health Care Providers & Services Spread above Index P+450 Floor 1.00% Interest Rate 13.00% Acquisition Date 2/12/2021 Maturity Date 2/12/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 8,373
Spread above Index	[1],[2]		450%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Tilley Distribution, Inc Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 11.50% Acquisition Date 12/8/2021 Maturity Date 13/31/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 12,331
Spread above Index	[1],[2]		600%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Transportation Insight, LLC Industry Road & Rail Spread above Index S+450 Floor 1.00% Interest Rate 9.98% Acquisition Date 10/27/2021 Maturity Date 12/18/2024
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 5,780
Spread above Index	[1],[2]		450%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Ultimate Baked Goods Midco LLC (Rise Baking) Industry Packaged Foods & Meats Spread above Index S+625 Floor 1.00% Interest Rate 11.71% Acquisition Date 8/12/2021 Maturity Date 8/13/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 7,479
Spread above Index	[1],[2]		625%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Vapotherm, Inc Industry Health Care Equipment & Supplies Spread above Index S+930 Floor 1.00% Interest Rate 14.75% Acquisition Date 2/18/2022 Maturity Date 2/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 13,394
Spread above Index	[1],[2]		930%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% Vessco Midco Holdings, LLC Industry Water Utilities Spread above Index S+450 Floor 1.00% Interest Rate 9.96% Acquisition Date 9/3/2021 Maturity Date 11/2/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 5,513
Spread above Index	[1],[2]		450%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 151.5% iCIMS, Inc Industry Software Spread above Index S+725 Floor 0.75% Interest Rate 12.62% Acquisition Date 8/18/2022 Maturity Date 8/18/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[1]		$ 14,195
Spread above Index	[1],[2]		725%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1%
Schedule of Investments [Line Items]
Investment Owned, Fair Value		$ 330,577
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% AMF Levered II, LLC Industry Diversified Financial Services Spread above Index S+705 Floor 1.00% Interest Rate 12.02% Acquisition Date 12/24/2021 Maturity Date 8/21/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 12,660
Spread above Index	[7],[8]	705%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% All States Ag Parts, LLC Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 10.96% Acquisition Date 9/1/2021 Maturity Date 9/1/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 5,126
Spread above Index	[7],[8]	600%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Arcutis Biotherapeutics, Inc Industry Pharmaceuticals Spread above Index S+595 Floor 2.50% Interest Rate 11.12% Acquisition Date 12/22/2021 Maturity Date 8/1/2029
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7],[9]	$ 25,922
Spread above Index	[7],[8],[9]	595%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Ardelyx, Inc Industry Pharmaceuticals Spread above Index S+795 Floor 1.00% Interest Rate 13.14% Acquisition Date 2/23/2022 Maturity Date 3/1/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7],[9]	$ 6,216
Spread above Index	[7],[8],[9]	795%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% BayMark Health Services, Inc Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 9.87% Acquisition Date 6/29/2021 Maturity Date 6/11/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 15,580
Spread above Index	[7],[8]	500%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% CC SAG Holdings Corp. (Spectrum Automotve) Industry Diversified Consumer Services Spread above Index S+575 Floor 0.75% Interest Rate 9.85% Acquisition Date 6/29/2021 Maturity Date 6/29/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 12,449
Spread above Index	[7],[8]	525%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Cerapedics, Inc Industry Biotechnology Spread above Index S+620 Floor 2.75% Interest Rate 11.53% Acquisition Date 12/27/2022 Maturity Date 1/1/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 12,416
Spread above Index	[7],[8]	620%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) Industry Trading Companies & Distributors Spread above Index S+475 Floor 1.00% Interest Rate 9.45% Acquisition Date 12/31/2019 Maturity Date 12/31/2025
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 7,134
Spread above Index	[7],[8]	475%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Enhanced Permanent Capital, LLC Industry Capital Markets Spread above Index S+700 Floor 1.00% Interest Rate 12.44% Acquisition Date 12/29/2020 Maturity Date 12/29/2025
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7],[9]	$ 9,501
Spread above Index	[7],[8],[9]	700%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Erie Construction Mid-west, LLC Industry Building Products Spread above Index S+475 Floor 1.00% Interest Rate 10.08% Acquisition Date 8/5/2021 Maturity Date 7/30/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 10,359
Spread above Index	[7],[8]	475%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Fertility (ITC) Investment Holdco, LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.74% Acquisition Date 1/4/2023 Maturity Date 1/3/2029
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 10,200
Spread above Index	[7],[8]	650%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Foundation Consumer Brands, LLC Industry Personal Products Spread above Index S+625 Floor 1.00% Interest Rate 11.50% Acquisition Date 02/12/2021 Maturity Date 02/12/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 10,885
Spread above Index	[7],[8]	625%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% High Street Buyer, Inc. Industry Insurance Spread above Index S+525 Floor 0.75% Interest Rate 9.85% Acquisition Date 04/16/2021 Maturity Date 04/16/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 11,885
Spread above Index	[7],[8]	525%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Human Interest Inc. Industry Internet Software & Services Spread above Index S+735 Floor 1.00% Interest Rate 12.55% Acquisition Date 06/30/2022 Maturity Date 07/01/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 13,598
Spread above Index	[7],[8]	735%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Kaseya, Inc. Industry Software Spread above Index S+550 Floor 0.75% Interest Rate 10.75% Acquisition Date 06/22/2022 Maturity Date 06/23/2029
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 11,213
Spread above Index	[7],[8]	550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Meditrina, Inc. Industry Health Care Equipment & Supplies Spread above Index S+550 Floor 3.45% Interest Rate 10.67% Acquisition Date 12/20/2022 Maturity Date 12/01/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 1,836
Spread above Index	[7],[8]	550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Nexus Intermediate III, LLC (Vortex) Industry Professional Services Spread above Index S+550 Floor 0.75% Interest Rate 10.71% Acquisition Date 12/13/2021 Maturity Date 12/06/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 5,243
Spread above Index	[7],[8]	550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Orthopedic Care Partners Management, LLC Industry Health Care Providers & Services Spread above Index S+650 Floor 1.00% Interest Rate 11.46% Acquisition Date 08/17/2022 Maturity Date 11/15/2024
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 6,318
Spread above Index	[7],[8]	650%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Outset Medical, Inc. Industry Health Care Equipment & Supplies Spread above Index S+515 Floor 2.75% Interest Rate 10.32% Acquisition Date 11/03/2022 Maturity Date 11/01/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 17,468
Spread above Index	[7],[8]	515%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Peter C. Foy & Associates Insurance Services, LLC Industry Insurance Spread above Index S+550 Floor 0.75% Interest Rate 10.59% Acquisition Date 10/29/2021 Maturity Date 11/01/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 15,304
Spread above Index	[7],[8]	550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Plastic Management, LLC Industry Health Care Providers & Services Spread above Index S+500 Floor 1.00% Interest Rate 9.70% Acquisition Date 08/26/2021 Maturity Date 08/18/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 14,942
Spread above Index	[7],[8]	500%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% RQM+ Corp. Industry Life Sciences Tools & Services Spread above Index S+575 Floor 1.00% Interest Rate 10.62% Acquisition Date 08/20/2021 Maturity Date 08/12/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 14,787
Spread above Index	[7],[8]	575%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% RxSense Holdings LLC Industry Diversified Consumer Services Spread above Index S+500 Floor 1.00% Interest Rate 10.35% Acquisition Date 03/17/2020 Maturity Date 03/13/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 14,373
Spread above Index	[7],[8]	500%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Southern Orthodontic Partners Management, LLC Industry Health Care Providers & Services Spread above Index S+550 Floor 1.00% Interest Rate 10.10% Acquisition Date 06/03/2022 Maturity Date 07/27/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 4,441
Spread above Index	[7],[8]	550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% SunMed Group Holdings, LLC Industry Health Care Equipment & Supplies Spread above Index S+550 Floor 0.75% Interest Rate 10.46% Acquisition Date 06/16/2021 Maturity Date 06/16/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 8,061
Spread above Index	[7],[8]	550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% TAUC Management, LLC Industry Health Care Providers & Services Spread above Index S+700 Floor 1.00% Interest Rate 11.75% Acquisition Date 02/12/2021 Maturity Date 02/12/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 8,213
Spread above Index	[7],[8],[10]	700%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Tilley Distribution, Inc. Industry Trading Companies & Distributors Spread above Index S+600 Floor 1.00% Interest Rate 10.75% Acquisition Date 12/08/2021 Maturity Date 12/31/2026
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 11,661
Spread above Index	[7],[8]	600%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Transportation Insight, LLC Industry Road & Rail Spread above Index S+550 Floor 1.00% Interest Rate 9.93% Acquisition Date 10/27/2021 Maturity Date 12/18/2024
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 5,416
Spread above Index	[7],[8],[11]	550%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Ultimate Baked Goods Midco LLC (Rise Baking) Industry Packaged Foods & Meats Spread above Index S+625 Floor 1.00% Interest Rate 11.34% Acquisition Date 08/12/2021 Maturity Date 08/13/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 7,824
Spread above Index	[7],[8]	625%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% Vapotherm, Inc. Industry Health Care Equipment & Supplies Spread above Index S+600 Floor 4.50% Interest Rate 10.97% Acquisition Date 02/18/2022 Maturity Date 09/20/2027
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[12]	$ 4,975
Spread above Index	[8],[12]	600%
Investment, Identifier [Axis]: Bank Debt/Senior Secured Loans — 173.1% iCIMS, Inc. Industry Software Spread above Index S+725 Floor 0.75% Interest Rate 10.67% Acquisition Date 08/18/2022 Maturity Date 08/18/2028
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[7]	$ 14,571
Spread above Index	[7],[8]	725%
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants
Schedule of Investments [Line Items]
Investment Owned, Fair Value		$ 13,765
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Assertio Holdings, Inc. Common Stock Industry Pharmaceuticals Acquisition Date 7/31/2023
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[3],[13]		$ 5
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Meditrina, Inc. Warrants Industry Health Care Equipment & Supplies Acquisition Date 12/20/2022
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[3]		7
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 5.3% Senseonics Holdings, Inc Common Stock Industry Health Care Equipment & Supplies Acquisition Date 7/25/2019
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[3],[6],[13]		45
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Assertio Holdings, Inc. Common Stock Industry Pharmaceuticals Acquisition Date 7/31/2023
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[14]	5
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Centrexion Therapeutics, Inc. Warrants Industry Pharmaceuticals Acquisition Date 6/28/2019
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[15]	6
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Meditrina, Inc. Warrants Industry Health Care Equipment & Supplies Acquisition Date 12/20/2022
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[15]	10
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% SLR-AMI Topco Blocker, LLC Industry Internet & Catalog Retail Acquisition Date 6/16/2023
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[12],[16]	13,492
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Senseonics Holdings, Inc Common Stock Industry Health Care Equipment & Supplies Acquisition Date 7/25/2019
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[14]	28
Investment, Identifier [Axis]: Common Equity/Equity Interests/Warrants — 7.2% Veronica Holdings, LLC Industry Health Care Equipment & Supplies Acquisition Date 2/18/2022
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[12]	224
Investment, Identifier [Axis]: Liabilities in Excess of Other
Schedule of Investments [Line Items]
Investment Owned, Fair Value			(152,267)
Investment, Identifier [Axis]: Liabilities in Excess of Other Assets - (85.5%)
Schedule of Investments [Line Items]
Investment Owned, Fair Value		(163,332)
Investment, Identifier [Axis]: Net Assets — 100.0%
Schedule of Investments [Line Items]
Investment Owned, Fair Value		191,008	268,301
Investment, Identifier [Axis]: Oldco AI, LLC (f/k/a Amerimark)
Schedule of Investments [Line Items]
Investment Owned, Fair Value			0	8,243
Gross Reductions			(15,016)
Realized Gain (Loss)			0
Change in Unrealized Gain (Loss)			6,773
Interest/Dividend Income			0
Investment, Identifier [Axis]: Oldco AI, LLC (f/k/a Amerimark) One
Schedule of Investments [Line Items]
Investment Owned, Fair Value			0	0
Gross Additions			1,110
Gross Reductions			(1,110)
Realized Gain (Loss)			0
Change in Unrealized Gain (Loss)			0
Interest/Dividend Income			171
Investment, Identifier [Axis]: Preferred Equity — 5.2%
Schedule of Investments [Line Items]
Investment Owned, Fair Value		9,998
Investment, Identifier [Axis]: Preferred Equity — 5.2% Veronica Holdings, LLC (Vapotherm) Industry Health Care Equipment & Supplies Interest Rate 9.00% PIK Acquisition Date 9/20/2024
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[12]	$ 9,998
Investment, Interest Rate, Paid in Kind	[12]	9%
Investment, Identifier [Axis]: SLR-AMI Topco Blocker, LLC
Schedule of Investments [Line Items]
Investment Owned, Fair Value		$ 13,492	13,958	$ 6,170
Gross Additions		0	15,016
Gross Reductions		0	0
Realized Gain (Loss)		0	0
Change in Unrealized Gain (Loss)		(466)	(7,228)
Interest/Dividend Income		0	0
Investment, Identifier [Axis]: Total Bank Debt/Senior Secured Loans
Schedule of Investments [Line Items]
Investment Owned, Fair Value			406,543
Investment, Identifier [Axis]: Total Common Equity/Equity
Schedule of Investments [Line Items]
Investment Owned, Fair Value			14,025
Investment, Identifier [Axis]: Total Investments — 185.5%
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[17]	354,340
Investment, Identifier [Axis]: Total Investments(10) — 156.8%
Schedule of Investments [Line Items]
Investment Owned, Fair Value	[18]		420,568
Investment, Identifier [Axis]: Vapotherm, Inc.
Schedule of Investments [Line Items]
Investment Owned, Fair Value		4,975	0
Gross Additions		4,947
Gross Reductions		0
Realized Gain (Loss)		0
Change in Unrealized Gain (Loss)		26
Interest/Dividend Income		18
Investment, Identifier [Axis]: Veronica Holdings, LLC (Common Equity)
Schedule of Investments [Line Items]
Investment Owned, Fair Value		224	0
Gross Additions		118
Gross Reductions		0
Realized Gain (Loss)		0
Change in Unrealized Gain (Loss)		106
Interest/Dividend Income		0
Investment, Identifier [Axis]: Veronica Holdings, LLC (Preferred Equity)
Schedule of Investments [Line Items]
Investment Owned, Fair Value		9,998	$ 0
Gross Additions		9,487
Gross Reductions		0
Realized Gain (Loss)		0
Change in Unrealized Gain (Loss)		507
Interest/Dividend Income		$ 32

[1] Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC. Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor. Non-income producing security. Denotes investments in which the Company is an “Affiliated Person” but does not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the period June 16, 2023 (date at which the Company became an “Affiliated Person”) through December 31, 2023 in these affiliated investments are as follows: Through this entity and other intermediate entities, the Company owns approximately 6.5 % of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former AmeriMark Interactive, LLC. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If the Company fails to invest a sufficient portion of its assets in qualifying assets, it could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2023, on a fair value basis, non-qualifying assets in the Company’s portfolio represented 15.4% of the total assets of the Company. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC (the “SPV”). Such investments are pledged as collateral under the DB Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to SOFR or PRIME rate floor. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”). If the Company fails to invest a sufficient portion of its assets in qualifying assets, it could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2024, on a fair value basis, non-qualifying assets in the Company ’s portfolio represented 9.9% of the total assets of the Company. Spread is S+ 600 Cash/ 1.00 % PIK Spread is S+450 Cash / 1.00% PIK Denotes investments in which the Company is an “Affiliated Person” but does not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2024 in these affiliated investments are as follows: Name of Issuer Fair Value at Gross Gross Realized Gain Change in Unrealized Fair Value at Interest/Dividend SLR-AMI Topco Blocker, LLC $ 13,958 $ — $ — $ — $ ( 466 ) $ 13,492 $ — Vapotherm, Inc. — 4,947 — — 26 4,975 18 Veronica Holdings, LLC (Preferred Equity) — 9,487 — — 507 9,998 32 Veronica Holdings, LLC (Common Equity) — 118 — — 106 224 — $ 13,958 $ 14,552 $ — $ — $ 173 $ 28,689 $ 50 Denotes a Level 1 investment. Denotes a Level 1 investment. Non-income producing security. Through this entity and other intermediate entities, the Company owns approximately 5.0 % of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former AmeriMark Interactive, LLC. Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 8,864 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 4,240 and $ 13,104 , respectively, based on a tax cost of $ 363,204 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed Aggregate net unrealized depreciation for U.S. federal income tax purposes is $ 8,658 ; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $ 3,286 and $ 11,944 , respectively, based on a tax cost of $ 429,226 . The Company generally acquires its investments in private transactions exempt from registration under the Securities Act. These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 5,744	$ 7,284	$ 18,847	$ 13,256

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b51 Arr Modified [Flag]	false
Rule 10b51 Arr Modified [Flag]	false

N-2

N-2 - $ / shares		9 Months Ended
N-2 - $ / shares		Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Mar. 12, 2019
Cover [Abstract]
Entity Central Index Key		0001743415
Amendment Flag		false
Securities Act File Number		814-01294
Document Type		10-Q
Entity Registrant Name		SCP Private Credit Income BDC LLC
Entity Address, Address Line One		500 Park Avenue
Entity Address, City or Town		New York
Entity Address, State or Province		NY
Entity Address, Postal Zip Code		10022
City Area Code		212
Local Phone Number		993-1670
Entity Emerging Growth Company		true
Entity Ex Transition Period		false
General Description of Registrant [Abstract]
Risk Factors [Table Text Block]		Item 1A. R isk Factors In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 27, 2024 filing of our Annual Report on Form 10-K, which could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factor below, there have been no material changes during the nine months ended September 30, 2024 to the risk factors discussed in “Risk Factors” in the February 27, 2024 filing of our Annual Report on Form 10-K. General Economic and Market Risk . The value of the Company’s investments could be affected by factors affecting the economy and securities markets generally, such as real or perceived adverse economic conditions, supply and demand for particular instruments, changes in the general outlook for certain markets or corporate earnings, interest rates, announcements of political information or adverse investor sentiment generally. The market values of the Company’s investments may decline for a number of reasons, including increases in defaults resulting from changes in overall economic conditions and widening of credit spreads. Unfavorable market conditions may also increase funding costs, limit access to the capital markets or result in credit terms changing or credit becoming unavailable. These events could have an adverse effect on the Company’s investments and the Company’s overall performance. Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics) may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign trade, economic and other policies with other countries, the large-scale invasion of Ukraine by Russia that began in February 2022 and resulting sanctions or other restrictive actions that the United States and other countries have imposed against Russia, the COVID-19 pandemic, certain regional bank failures, an inflationary environment and the ongoing war in the Middle East, could adversely affect the Company’s business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of the Company’s Portfolio Investments. Additionally, the Federal Reserve raised the federal funds rate in 2022 and 2023. While the Federal Reserve cut its benchmark rate in the third quarter of 2024 for the first time since March 2020 and indicated that there may be additional rate cuts in 2024, future reductions to benchmark rates are not certain. Additionally, there can be no assurance that the Federal Reserve will not return to making upwards adjustments to the federal funds rate in the future. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts of COVID-19, could cause interest rates to be volatile, which may negatively impact the Company’s ability to access the debt markets and capital markets on favorable terms. Continuing market uncertainty may have a significant impact on the business of the Company. During this period, the returns (if any) realized by Unitholders may be substantially adversely affected by the unfavorable performance of the Company’s investments. Furthermore, market conditions may unfavorably impact the Company’s ability to secure leverage on commercially favorable terms. Increases in interest rates or in the risk spread demanded by financing sources would make the use of leverage more expensive. In addition, the Company may not be able to time the disposition of its investments correctly, which could result in further depreciation in values.
Share Price						$ 10
NAV Per Share	[1]	$ 10.31	$ 10.04	$ 10.64	$ 10.33

[1] Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively.

Organization

Organization	9 Months Ended
Organization	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Note 1. Organization SCP Private Credit Income BDC LLC (the “Company”, “we”, “us” or “our”) is a Delaware limited liability company formed on May 18, 2018. The Company is an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it applies the guidance in the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company was formed primarily to provide investors with attractive long-term returns through investments made pursuant to the investment strategy of the Company described below (the Company’s investments in portfolio companies are referred to herein as “Portfolio Investments”). On October 5, 2018 (the “Initial Closing Date”), the Company closed on $ 326,000 in capital commitments. On March 12, 2019, the sale and issuance of 2,800,000 of the Company’s units (“Units”), at an aggregate purchase price of $ 28,000 ($ 10.00 per Unit), occurred and the Company commenced operations. As of September 30, 2024, $ 194,300 of capital commitments were drawn and $ 131,700 were unfunded. The Company has implemented a corporate lending strategy focused on sourcing, underwriting and managing a diverse portfolio of private senior secured loans primarily to upper middle market companies (generally, aggregate loan sizes of $ 100,000 to $ 300,000 to companies with earnings before interest, tax, depreciation and amortization (“EBITDA”) between approximately $ 25,000 and $ 100,000 ) across the United States. In addition to senior secured loans to upper middle market companies, the Company intends to invest a portion of its assets in non-traditional asset-based loans and first lien loans to rapidly growing healthcare companies. The Company also expects that some of its investments will contain delayed-draw term loan type features and/or other types of unfunded commitments. The offering period of the Company ended on April 5, 2019 (the “Offering Period”). The investment period of the Company ended on December 31, 2022. The term of the Company will be six years from the end of the Offering Period unless the Company is liquidated earlier as set forth in the Limited Liability Company Agreement of the Company (as amended, restated or otherwise modified from time to time, the “LLC Agreement”), but may be extended by the Company’s Board of Directors (the “Board”) for up to two consecutive one-year periods upon approval of the Company’s independent directors and the approval of unitholders of the Company (“Unitholders”), which approval will be obtained through a non-1940 Act vote as described in the LLC Agreement. The Company may be dissolved and its affairs wound up prior to the end of the term under the circumstances set forth in the LLC Agreement. The fiscal year end of the Company is December 31.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”) and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to current period presentation. Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the reported period. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2024. In the opinion of management, all adjustments which are of a normal recurring nature considered necessary for the fair presentation of consolidated financial statements have been included. The significant accounting policies consistently followed by the Company are: (a) Investment transactions are accounted for on the trade date; (b) In accordance with GAAP and the 1940 Act, the Company’s assets will generally be valued as follows: (i) securities or other instruments (other than as referred to in clauses (ii) and (iii) below) for which market quotes are readily available and deemed to represent fair value under GAAP will be valued based on quotes obtained from a quotation reporting system, market makers or pricing services (when deemed to represent fair value under GAAP). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation; (ii) exchange-traded options, futures and options on futures will be valued at the settlement price determined by the exchange or through the use of a model such as Black-Scholes; (iii) short-term investments with maturities of sixty (60) days or less generally will be valued at amortized cost; and (iv) securities, loans or other instruments for which market quotes are not readily available or reliable under GAAP will be valued as described below: a. the quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of SLR Capital Partners, LLC (the “Adviser”) responsible for the Portfolio Investment; b. preliminary valuation conclusions are then documented and discussed with senior management of the Adviser; c. the audit committee of the Board reviews the preliminary valuations of the Adviser and third-party valuation specialist, if any, and responds to the valuation recommendations to reflect any comments; and d. the Board discusses valuations and determines the fair value of each investment in the Company’s portfolio in good faith based on the input of the Adviser, the audit committee, and third-party valuation specialist, if any, which may from time to time be engaged by the Board. The valuation principles set forth above may be modified from time to time without notice to Unitholders, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule 2a-5 under the 1940 Act; and (6) maintain recordkeeping requirements under Rule 2a-5. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material. Investments are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the nine months ended September 30, 2024, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process. ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: Level 1 : Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date. Level 2 : Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. Level 3 : Unobservable inputs for the asset or liability. In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. (c) Gains or losses on investments are calculated by using the specific identification method. (d) The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized, and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income, as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned. (e) The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4 % excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. (f) Book and tax basis differences relating to Unitholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP. (g) Distributions to Unitholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. (h) In accordance with Regulation S-X and ASC Topic 810— Consolidation , the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company. (i) The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against the U.S. dollar on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. (j) In accordance with ASC 835-30, the Company reports origination and other expenses related to certain debt issuances, if any, as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. (k) The Company records expenses related to applicable equity offering costs as a charge to capital upon the sale of Units, in accordance with ASC 946-20-25. (l) Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment. (m) The Company records expenses directly related to its organization as incurred. (n) The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

Agreements and Related Party Tr

Agreements and Related Party Transactions	9 Months Ended
Agreements and Related Party Transactions	Sep. 30, 2024
Agreements And Related Party Transactions [Abstract]
Agreements and Related Party Transactions	Note 3. Agreements and Related Party Transactions The Company has entered into an investment management agreement with the Adviser (the “Investment Management Agreement”) pursuant to which it will pay management fees, administrative coordinator fees and incentive fees to the Adviser. The Company will pay the Adviser a fee for investment advisory and management services consisting of two components: a base management fee and an incentive fee. The Company will also pay the Adviser (in its capacity as Administrative Coordinator, defined herein) an administration fee for administrative and coordination services. The cost of the base management fee, the incentive fee, and the administration fee will be borne by the Unitholders. Management Fees and Administration Fees The Company will pay the Adviser a management fee (the “Management Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (each such date, the “Management Fee Calculation Date”), in an amount equal to 1.5 % per annum of Invested Capital (defined as, as of any date, the sum of (i) capital contributions to the Company plus (ii) the total amount of credit drawn on subscription credit facilities), and payable quarterly in arrears after such Management Fee Calculation Date. Pursuant to the Investment Management Agreement, the Adviser has also been appointed to provide administrative and coordination services to the Company (in such capacity, the “Administrative Coordinator”). The Company will pay the Administrative Coordinator a fee (the “Administration Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (the “Administration Fee Calculation Date”), in an amount equal to 0.08 % per annum of the average Cost Basis (defined as the aggregate accreted and amortized cost of all Portfolio Investments, including any amounts reinvested in investments and the cost of investments acquired using leverage), as measured on the last day of the preceding quarter and the last day of the current quarter for the period ended and payable quarterly in arrears after such Administration Fee Calculation Date. The Administrative Coordinator will be responsible for all expenses of its own staff responsible for (i) certain on-going, routine, non-investment-related administrative services for the Company, (ii) the coordination of various third-party services needed or required by the Company and (iii) certain Unitholder servicing functions. Each of the Management Fee and the Administration Fee will be appropriately adjusted for any stub period. Such fees will be paid out of net current income and/or disposition proceeds or, to the extent such amounts are not available, from unfunded capital commitments that will be drawn down, or borrowings of the Company. In the event that the Adviser arranges for the Company to pay any portion of a placement fee to a placement agent, the amount of Management Fees otherwise payable shall be reduced by an amount equal to 100 % of such payment to the placement agent. Incentive Fee The Company will make distributions out of two categories: Current Proceeds and Disposition Proceeds (collectively referred to as “Investment Proceeds”). “Disposition Proceeds” means all amounts received by the Company upon the disposition of an investment, including full or partial repayments or amortization of principal (but excluding Current Proceeds). “Current Proceeds” means all proceeds from investments, including interest income, fee income, warrant gains, prepayment fees and exit fees, other than Disposition Proceeds. The Adviser will apportion each Unitholder’s pro rata share of Investment Proceeds between Disposition Proceeds and Current Proceeds. Amounts of Investment Proceeds apportioned to Unitholders will be divided between and distributed to Unitholders, on the one hand, and the Adviser, on the other hand, in the following amounts and order of priority: (i) Disposition Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as an incentive fee, on the other hand, in the following amounts and order of priority: (A) Return of Capital Contributions . First, 100 % to such Unitholder until such Unitholder has received cumulative distributions of Investment Proceeds pursuant to this clause (i)(A) equal to such Unitholder’s total capital contributions to the Company (including amounts contributed to pay Management Fees, Administration Fees, Organizational Expenses (as defined below) and other Company expenses); (B) Unitholder Preferred Return . Second, 100 % of all remaining Disposition Proceeds to Unitholders until they have each received cumulative distributions of Investment Proceeds, without duplication, pursuant to this clause (B) and clause (D) below and pursuant to clause (ii)(A) and clause (ii)(C) below equal to 6 % per annum, compounded annually, on such Unitholder’s unreturned capital contributions to the Company (including amounts contributed to pay Management Fees, Administration Fees, Organizational Expenses and other Company expenses) (the “Preferred Return”); (C) Adviser Catch Up to 15 % . Third, 80 % of all remaining Disposition Proceeds paid to the Adviser as an incentive fee until the Adviser has received payments of Investment Proceeds with respect to Unitholders pursuant to this clause (C) and clause (ii)(B) equal to 15 % of the total amounts distributed to Unitholders and paid to the Adviser pursuant to clause (B) above and this clause (C) and pursuant to clause (ii)(A) and clause (ii)(B); and (D) 85 %/ 15 % Shares . Thereafter, 85 % to Unitholders and 15 % paid to the Adviser as an incentive fee. (ii) Current Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as an incentive fee, on the other hand, in the following amounts and order of priority: (A) Unitholder Preferred Return . First, 100 % of all Current Proceeds to Unitholders until Unitholders have received cumulative distributions of Investment Proceeds, without duplication, pursuant to this clause (A) and clause (C) below and pursuant to clause (i)(B) and clause (i)(D) equal to the Preferred Return; (B) Adviser Catch Up to 15 % . Second, 80 % of all remaining Current Proceeds paid to the Adviser as an incentive fee until the Adviser has received payments of Investment Proceeds with respect to Unitholders pursuant to this clause (B) and clause (i)(C) equal to 15 % of the total amounts distributed to Unitholders and paid to the Adviser pursuant to clause (A) above and this clause (B) and pursuant to Section clause (i)(B) and clause (i)(C); and (C) 85 %/ 15 % Units . Thereafter, 85 % to Unitholders and 15 % paid to the Adviser as an incentive fee. In no event will the Adviser receive amounts attributable to Disposition Proceeds that, as of any distribution or payment date, exceeds 20 % of cumulative realized capital gains net of all cumulative realized capital losses and unrealized capital depreciation. The Adviser has the right with respect to all Unitholders, upon approval of the Company’s independent directors, to waive or reduce the incentive fee to which it is entitled. The Adviser may also elect not to receive all or any portion of the incentive fee that would otherwise be distributed to it, and may cause any or all amounts subsequently available for distribution to the Unitholders to be distributed to the Adviser until it has received the same aggregate amount of incentive fees had it not previously waived receipt of incentive fees. The Adviser will be entitled to withhold from any distributions, in its discretion, any required tax withholdings. Amounts of taxes paid or withheld from amounts otherwise distributable to a Unitholder will be deemed distributed for purposes of the calculations above. Upon liquidation of the Company, the Adviser will be required to restore funds to the Company for distribution to the Unitholders if and to the extent that the Adviser has received cumulative incentive fees in excess of the incentive fees that would have been payable to the Adviser on an aggregate basis covering all transactions of the Company; provided, however, that in no event will the Adviser be required to contribute an aggregate amount in excess of 100 % of the net amount distributed to the Adviser (net of taxes) on account of its incentive fees. In addition, the Adviser will apply an interim incentive fee adjustment at the end of each fiscal year so that, in the event of any over-distribution of incentive fees to the Adviser (measured with respect to each Unitholder using the fair value of the Company’s portfolio at the end of the applicable fiscal year as if the Company were to liquidate on such date), future distributions that would, absent such interim incentive fee adjustment, otherwise be distributed to the Adviser as an incentive fee shall be distributed to such Unitholder until such over-distribution (net of taxes payable by the Adviser with respect to such incentive fee) has been eliminated. For the three and nine months ended September 30, 2024, the Company incurred $ 733 and $ 2,805 , respectively, in Management Fees, $ 77 and $ 241 , respectively, in Administration Fees and $ 1,014 and $ 3,326 , respectively in incentive fees. For the three and nine months ended September 30, 2023, the Company incurred $ 1,102 and $ 3,238 , respectively, in Management Fees, $ 105 and $ 315 , respectively, in Administration Fees and $ 1,285 and $ 2,339 , respectively, in incentive fees. The aggregate amount of certain annual operating expenses relating to Unitholders investing directly in the Company will not exceed the Operating Expense Cap, calculated as follows: (A) if the Company has less than or equal to $ 400,000 in capital commitments, an amount equal to the sum of (x) the product of the capital commitments and 0.0025 and (y) $ 1,250 , or (B) if the Company has greater than $ 400,000 in capital commitments, $ 2,250 . Any amount in excess of the Operating Expense Cap for any fiscal year will be paid by the Adviser. For the avoidance of doubt, the Operating Expense Cap will not apply to any fees, costs, expenses and liabilities allocable to persons investing indirectly in the Company through any Unitholder. The Adviser or Administrative Coordinator and/or their affiliates have advanced organizational and offering expenses to the Company, which include organizational fees, costs, expenses and liabilities of the Company, including legal expenses, incurred in connection with the initial offering of Units and the formation and establishment of the Company (“Organizational Expenses”). The Adviser or Administrative Coordinator (or such affiliate) have been reimbursed by the Company for such advanced costs and expenses in an amount that did not exceed $ 500 . $ 308 of offering expenses were charged to capital and $ 84 of organizational costs were expensed in 2019.

Fair Value

Fair Value	9 Months Ended
Fair Value	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value	Note 4. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1. Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access. Level 2. Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: a) Quoted prices for similar assets or liabilities in active markets; b) Quoted prices for identical or similar assets or liabilities in non-active markets; c) Pricing models whose inputs are observable for substantially the full term of the asset or liability; and d) Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. Level 3. Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2024 and December 31, 2023: Fair Value Measurements As of September 30, 2024 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 330,577 $ 330,577 Preferred Equity — — 9,998 9,998 Common Equity/Equity Interests/Warrants 33 — 13,732 13,765 Total Investments $ 33 $ — $ 354,307 $ 354,340 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at September 30, 2024, the fair value of the DB Facility and the Subscription Facility (as defined in Note 5 to the consolidated financial statements) would be $ 226,118 and $ 0 , respectively. All debt obligations would be considered Level 3 liabilities and would be valued with market yield as the unobservable input. Fair Value Measurements As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 406,543 $ 406,543 Common Equity/Equity Interests/Warrants 50 — 13,975 14,025 Total Investments $ 50 $ — $ 420,518 $ 420,568 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2023, the fair value of the SPV Facility and the Subscription Facility would be $ 170,800 and $ 0 , respectively. All debt obligations would be considered Level 3 liabilities and would be valued with market yield as the unobservable input. The following tables provide a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2024, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2024: Bank Debt/Senior Preferred Equity Common Equity/Equity Total Fair value, June 30, 2024 $ 383,948 $ — $ 14,000 $ 397,948 Total gains or losses included in earnings: Net realized gain — — — — Net change in unrealized gain (loss) ( 421 ) 507 ( 268 ) ( 182 ) Purchase of investment securities* 9,403 9,491 117 19,011 Proceeds from dispositions of investment securities ( 62,353 ) — ( 117 ) ( 62,470 ) Transfers into Level 3 — — — — Transfers out of Level 3 — — — — Fair value, September 30, 2024 $ 330,577 $ 9,998 $ 13,732 $ 354,307 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ ( 421 ) $ 507 $ ( 268 ) $ ( 182 ) * Includes PIK capitalization and accretion of discount Bank Debt/Senior Preferred Equity Common Equity/Equity Total Fair value, December 31, 2023 $ 406,543 $ — $ 13,975 $ 420,518 Total gains or losses included in earnings: Net realized gain 41 — — 41 Net change in unrealized gain (loss) ( 445 ) 507 ( 251 ) ( 189 ) Purchase of investment securities* 14,581 9,491 125 24,197 Proceeds from dispositions of investment securities ( 90,143 ) — ( 117 ) ( 90,260 ) Transfers into Level 3 — — — — Transfers out of Level 3 — — — — Fair value, September 30, 2024 $ 330,577 $ 9,998 $ 13,732 $ 354,307 Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain $ ( 269 ) $ 507 $ ( 251 ) $ ( 13 ) * Includes PIK capitalization and accretion of discount The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2023: Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Total gains or losses included in earnings: Net realized gain 12 — 12 Net change in unrealized loss ( 1,678 ) ( 7,294 ) ( 8,972 ) Purchase of investment securities* 95,190 21,226 116,416 Proceeds from dispositions of investment securities ( 219,734 ) ( 17 ) ( 219,751 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, December 31, 2023 $ 406,543 $ 13,975 $ 420,518 Unrealized losses for the period relating to Net change in unrealized loss $ ( 1,534 ) $ ( 7,306 ) $ ( 8,840 ) * Includes PIK capitalization and accretion of discount Quantitative Information about Level 3 Fair Value Measurements The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and EBITDA multiples of similar companies, and comparable market transactions for equity securities. Quantitative information about the Company’s Level 3 asset fair value measurements as of September 30, 2024 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 330,577 Income Approach Market Yield 9.6 % - 17.2 % ( 11.7 %) Preferred Equity Asset $ 9,998 Income Approach Market Yield 9.0 % - 9.0 % ( 9.0 %) Common Equity/Equity Interests/Warrants Asset $ 16 Market Approach Volatility 18.3 % - 18.3 % ( 18.3 %) $ 224 Transaction Price* N/A N/A $ 13,492 EBITDA Multiple Comparable Multiple 5.5 x- 6.5 x ( 6.0 x) * This asset was valued at $ 2.18 per share, which is the price per share paid to the stockholders at the time of the closing of the transaction. Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, would result in a significantly lower or higher fair value measurement for such assets. Generally, an increase in market yields may result in a decrease in the fair value of certain of the Company’s investments. Weighted averages in the above table are calculated based on the fair value of the underlying assets. Quantitative information about the Company’s Level 3 asset fair value measurements as of December 31, 2023 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 406,543 Income Approach Market Yield 10.0 % - 17.6 % ( 12.2 %) Common Equity/Equity Interests/Warrants Asset $ 17 Market Approach Volatility 18.9 % - 18.9 % ( 18.9 %) $ 13,958 EBITDA Multiple Comparable Multiple 5.5 x- 6.5 x ( 6.0 x) Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, would result in a significantly lower or higher fair value measurement for such assets. Generally, an increase in market yields may result in a decrease in the fair value of certain of the Company’s investments

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2024
Debt Disclosure [Abstract]
Debt	Note 5. Debt Revolving credit facility due August 2024 (the “ SPV Facility”) —On February 27, 2019, the Company, through its wholly-owned subsidiary, SCP Private Credit Income BDC SPV LLC (the “SPV”), entered into the SPV Facility with JPMorgan Chase Bank, N.A. acting as administrative agent. Effective with the latest amendment dated October 20, 2023, the stated interest rate on the SPV Facility was SOFR plus 2.70 % with no floor requirement and the final maturity date was August 15, 2024 . Maximum commitments were $ 261,388 . On August 2, 2024, the Company prepaid the SPV Facility in full. Term credit facility due August 2027 (the “ DB Facility”) —On August 2, 2024, the Company and the SPV established the DB Facility with Deutsche Bank AG, New York Branch as lender. The DB Facility has a total commitment of approximately $ 226,118 , a maturity date of August 2, 2027 and an applicable margin of S+265. The DB Facility is secured by all of the assets held by the SPV. Under the terms of the DB Facility, the Company and SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The DB Facility also includes usual and customary events of default for credit facilities of this nature. As of September 30, 2024, there were $ 226,118 of borrowings outstanding under the DB Facility. Revolving credit facility due December 2024 (the “ Subscription Facility”) —During the first quarter of 2019, the Company established the Subscription Facility with East West Bank. Effective with the latest amendment dated December 22, 2023, the Subscription Facility’s size is $ 32,000 with a stated interest rate of SOFR plus 2.95 % and a maturity date of December 31, 2024 . Under the terms of the Subscription Facility, the Company has made certain customary representations and warranties and is required to comply with various covenants, including reporting requirements and other customary requirements for similar credit facilities. The Subscription Facility also includes usual and customary events of default for credit facilities of this nature. As of September 30, 2024, there were no borrowings outstanding under the Subscription Facility. The average annualized interest cost for borrowings for the nine months ended September 30, 2024 and the year ended December 31, 2023 was 8.08 % and 8.08 %, respectively. These costs are exclusive of other credit facility expenses such as unused fees and fees paid to the back-up servicer, if any. The maximum amount borrowed on the credit facilities during the nine months ended September 30, 2024 and the year ended December 31, 2023 was $ 226,118 and $ 338,126 , respectively.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6. Commitments and Contingencies The Company had unfunded debt commitments to various revolving and delayed-draw term loans. The total amount of these unfunded commitments as of September 30, 2024 and December 31, 2023 was $ 6,167 and $ 14,730 , respectively, comprised of the following: September 30, December 31, iCIMS, Inc. $ 1,932 $ 2,308 RxSense Holdings, LLC 1,558 1,558 Foundation Consumer Brands, LLC 967 967 ENS Holdings III Corp. & ES Opco USA LLC 502 717 Ultimate Baked Goods Midco LLC 414 749 TAUC Management, LLC 385 385 Transportation Insight, Inc. 235 — CC SAG Holdings Corp. (Spectrum Automotive) 174 174 High Street Buyer, Inc. — 1,890 Nexus Intermediate III, LLC (Vortex) — 1,264 Kid Distro Holdings, LLC — 1,121 GSM Acquisition Corp. — 1,101 Basic Fun, Inc. — 960 Kaseya, Inc. — 625 SunMed Group Holdings, LLC — 515 Vessco Midco Holdings, LLC — 396 Total Commitments $ 6,167 $ 14,730 The credit agreements governing the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2024 and December 31, 2023, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment. In the normal course of our business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities. As of September 30, 2024, we held no such contracts. From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. As of September 30, 2024 and December 31, 2023, management is not aware of any material pending or threatened litigation that would require accounting recognition or financial statement disclosure.

Unitholders' Capital

Unitholders' Capital	9 Months Ended
Unitholders' Capital	Sep. 30, 2024
Limited Liability Company (LLC) Members' Equity [Abstract]
Unitholders' Capital	Note 7. Unitholders’ Capital Transactions in Unitholders’ capital were as follows: Three months ended Three months ended Units at beginning of period 26,710,775 25,190,253 Units issued — — Units redeemed ( 8,178,256 ) — Units issued and outstanding at end of period 18,532,519 25,190,253 Nine months ended Nine months ended Units at beginning of period 26,710,775 18,992,563 Units issued — 6,197,690 Units redeemed ( 8,178,256 ) — Units issued and outstanding at end of period 18,532,519 25,190,253

Financial Highlights

Financial Highlights	9 Months Ended
Financial Highlights	Sep. 30, 2024
Investment Company, Financial Highlights [Abstract]
Financial Highlights	Note 8. Financial Highlights The following is a schedule of financial highlights for the nine months ended September 30, 2024 and September 30, 2023: Nine months ended Nine months ended Per Share Data: (a) Net asset value per Unit, beginning of period $ 10.04 $ 10.33 Net investment income 0.71 0.89 Net realized and unrealized gain (loss)* 0.04 ( 0.31 ) Net increase in Unitholders’ capital resulting from operations 0.75 0.58 Distributions to Unitholders: From distributable earnings ( 0.48 ) ( 0.27 ) Net asset value per Unit, end of period $ 10.31 $ 10.64 Total Return (b)(c) 7.47 % 5.61 % Unitholders’ capital, end of period $ 191,008 $ 267,973 Units outstanding, end of period 18,532,519 25,190,253 Ratios to average net assets of Unitholders’ Net investment income 7.02 % 8.57 % Operating expenses 2.57 % 2.63 % Interest and other credit facility expenses 4.15 % 7.11 % Total expenses 6.72 % 9.74 % Average debt outstanding $ 169,115 $ 274,782 Portfolio turnover ratio 5.3 % 15.9 % (a) Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively. (b) Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. (c) Not annualized for periods less than one year. * Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 9. Subsequent Events The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. There have been no additional subsequent events that require recognition or disclosure in these consolidated financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
Fair Value (Tables)	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Summary of assets measured at fair value on a recurring basis	The following tables present the balances of assets measured at fair value on a recurring basis, as of September 30, 2024 and December 31, 2023: Fair Value Measurements As of September 30, 2024 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 330,577 $ 330,577 Preferred Equity — — 9,998 9,998 Common Equity/Equity Interests/Warrants 33 — 13,732 13,765 Total Investments $ 33 $ — $ 354,307 $ 354,340 Fair Value Measurements As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 406,543 $ 406,543 Common Equity/Equity Interests/Warrants 50 — 13,975 14,025 Total Investments $ 50 $ — $ 420,518 $ 420,568
Summary of the changes in fair value of level 3 assets	The following tables provide a summary of the changes in fair value of Level 3 assets for the three and nine months ended September 30, 2024, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at September 30, 2024: Bank Debt/Senior Preferred Equity Common Equity/Equity Total Fair value, June 30, 2024 $ 383,948 $ — $ 14,000 $ 397,948 Total gains or losses included in earnings: Net realized gain — — — — Net change in unrealized gain (loss) ( 421 ) 507 ( 268 ) ( 182 ) Purchase of investment securities* 9,403 9,491 117 19,011 Proceeds from dispositions of investment securities ( 62,353 ) — ( 117 ) ( 62,470 ) Transfers into Level 3 — — — — Transfers out of Level 3 — — — — Fair value, September 30, 2024 $ 330,577 $ 9,998 $ 13,732 $ 354,307 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ ( 421 ) $ 507 $ ( 268 ) $ ( 182 ) * Includes PIK capitalization and accretion of discount Bank Debt/Senior Preferred Equity Common Equity/Equity Total Fair value, December 31, 2023 $ 406,543 $ — $ 13,975 $ 420,518 Total gains or losses included in earnings: Net realized gain 41 — — 41 Net change in unrealized gain (loss) ( 445 ) 507 ( 251 ) ( 189 ) Purchase of investment securities* 14,581 9,491 125 24,197 Proceeds from dispositions of investment securities ( 90,143 ) — ( 117 ) ( 90,260 ) Transfers into Level 3 — — — — Transfers out of Level 3 — — — — Fair value, September 30, 2024 $ 330,577 $ 9,998 $ 13,732 $ 354,307 Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain $ ( 269 ) $ 507 $ ( 251 ) $ ( 13 ) * Includes PIK capitalization and accretion of discount The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2023: Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Total gains or losses included in earnings: Net realized gain 12 — 12 Net change in unrealized loss ( 1,678 ) ( 7,294 ) ( 8,972 ) Purchase of investment securities* 95,190 21,226 116,416 Proceeds from dispositions of investment securities ( 219,734 ) ( 17 ) ( 219,751 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, December 31, 2023 $ 406,543 $ 13,975 $ 420,518 Unrealized losses for the period relating to Net change in unrealized loss $ ( 1,534 ) $ ( 7,306 ) $ ( 8,840 ) * Includes PIK capitalization and accretion of discount
Summary of quantitative information about the company's level 3 asset fair value measurements	Quantitative information about the Company’s Level 3 asset fair value measurements as of September 30, 2024 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 330,577 Income Approach Market Yield 9.6 % - 17.2 % ( 11.7 %) Preferred Equity Asset $ 9,998 Income Approach Market Yield 9.0 % - 9.0 % ( 9.0 %) Common Equity/Equity Interests/Warrants Asset $ 16 Market Approach Volatility 18.3 % - 18.3 % ( 18.3 %) $ 224 Transaction Price* N/A N/A $ 13,492 EBITDA Multiple Comparable Multiple 5.5 x- 6.5 x ( 6.0 x) * This asset was valued at $ 2.18 per share, which is the price per share paid to the stockholders at the time of the closing of the transaction. Quantitative information about the Company’s Level 3 asset fair value measurements as of December 31, 2023 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Input Range (Weighted Senior Secured Loans Asset $ 406,543 Income Approach Market Yield 10.0 % - 17.6 % ( 12.2 %) Common Equity/Equity Interests/Warrants Asset $ 17 Market Approach Volatility 18.9 % - 18.9 % ( 18.9 %) $ 13,958 EBITDA Multiple Comparable Multiple 5.5 x- 6.5 x ( 6.0 x)

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
Commitments and Contingencies (Tables)	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Summary of unfunded commitments	The total amount of these unfunded commitments as of September 30, 2024 and December 31, 2023 was $ 6,167 and $ 14,730 , respectively, comprised of the following: September 30, December 31, iCIMS, Inc. $ 1,932 $ 2,308 RxSense Holdings, LLC 1,558 1,558 Foundation Consumer Brands, LLC 967 967 ENS Holdings III Corp. & ES Opco USA LLC 502 717 Ultimate Baked Goods Midco LLC 414 749 TAUC Management, LLC 385 385 Transportation Insight, Inc. 235 — CC SAG Holdings Corp. (Spectrum Automotive) 174 174 High Street Buyer, Inc. — 1,890 Nexus Intermediate III, LLC (Vortex) — 1,264 Kid Distro Holdings, LLC — 1,121 GSM Acquisition Corp. — 1,101 Basic Fun, Inc. — 960 Kaseya, Inc. — 625 SunMed Group Holdings, LLC — 515 Vessco Midco Holdings, LLC — 396 Total Commitments $ 6,167 $ 14,730

Unitholders' Capital (Tables)

Unitholders' Capital (Tables)	9 Months Ended
Unitholders' Capital (Tables)	Sep. 30, 2024
Limited Liability Company (LLC) Members' Equity [Abstract]
Summary of limited liability company unit holders capital	Transactions in Unitholders’ capital were as follows: Three months ended Three months ended Units at beginning of period 26,710,775 25,190,253 Units issued — — Units redeemed ( 8,178,256 ) — Units issued and outstanding at end of period 18,532,519 25,190,253 Nine months ended Nine months ended Units at beginning of period 26,710,775 18,992,563 Units issued — 6,197,690 Units redeemed ( 8,178,256 ) — Units issued and outstanding at end of period 18,532,519 25,190,253

Financial Highlights (Tables)

Financial Highlights (Tables)	9 Months Ended
Financial Highlights (Tables)	Sep. 30, 2024
Investment Company, Financial Highlights [Abstract]
Summary of investment company, financial highlights	The following is a schedule of financial highlights for the nine months ended September 30, 2024 and September 30, 2023: Nine months ended Nine months ended Per Share Data: (a) Net asset value per Unit, beginning of period $ 10.04 $ 10.33 Net investment income 0.71 0.89 Net realized and unrealized gain (loss)* 0.04 ( 0.31 ) Net increase in Unitholders’ capital resulting from operations 0.75 0.58 Distributions to Unitholders: From distributable earnings ( 0.48 ) ( 0.27 ) Net asset value per Unit, end of period $ 10.31 $ 10.64 Total Return (b)(c) 7.47 % 5.61 % Unitholders’ capital, end of period $ 191,008 $ 267,973 Units outstanding, end of period 18,532,519 25,190,253 Ratios to average net assets of Unitholders’ Net investment income 7.02 % 8.57 % Operating expenses 2.57 % 2.63 % Interest and other credit facility expenses 4.15 % 7.11 % Total expenses 6.72 % 9.74 % Average debt outstanding $ 169,115 $ 274,782 Portfolio turnover ratio 5.3 % 15.9 % (a) Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively. (b) Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. (c) Not annualized for periods less than one year. * Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end.

Organization - Additional Infor

Organization - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands			9 Months Ended
	Mar. 12, 2019	Oct. 05, 2018	Sep. 30, 2024
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investment company committed capital		$ 326,000
Stock issued during period shares new issues	2,800,000
Stock issued during period value new issues	$ 28,000
Share price	$ 10
Investment company funded capital commitments			$ 194,300
Investment company unfunded capital commitments			131,700
Minimum [Member] \| Investments [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investee maximum borrowings			100,000
Earnings before interest tax depreciation and amortization			25,000
Maximum [Member] \| Investments [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investee maximum borrowings			300,000
Earnings before interest tax depreciation and amortization			$ 100,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Percentage of excise tax	4%

Agreements and Related Party _2

Agreements and Related Party Transactions - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended		6 Months Ended	9 Months Ended
		Oct. 05, 2018	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024	Sep. 30, 2024	Sep. 30, 2023
Agreements And Related Party Transactions [Line Items]
Investment company, total return	[1],[2],[3]					7.47%	5.61%
Percentage of reimbursement of distributions by adviser upon liquidation			100%			100%
Percentage of cumulative realized capital gains net exceeds						20%
Management fee expense			$ 733	$ 1,102		$ 2,805	$ 3,238
Administrative fees expense			77	105		241	315
Incentive fee expense			$ 1,014	1,285		$ 3,326	2,339
Investment company committed capital		$ 326,000
First, Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
percentage of current proceeds to unitholders						100%
Second., Adviser Catch Up [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of total amount distributed to unitholders and advisers						15%
Percentage of Current Proceeds to Advisers						80%
Third Order of Priority Return of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of distribution to unitholders						85%
Percentage of distribution to adviser as an incentive fee						15%
Capital Commitment Condition One [Member]
Agreements And Related Party Transactions [Line Items]
Investment company committed capital						$ 400,000
Multiplier to capital commitment			0.0025			0.0025
Aggregate operating expenses relating to unitholders			$ 1,250			$ 1,250
Capital Commitment Condition Two [Member]
Agreements And Related Party Transactions [Line Items]
Investment company committed capital						400,000
Aggregate operating expenses relating to unitholders			2,250			$ 2,250
First Return Of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to unitholders						100%
Second Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to unitholders						100%
Third Adviser Catch Up [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to advisers						80%
Percentage of total amount distributed to unitholders and advisers					15%	15%
Fourth Order Of Priority Return Of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of distribution to unitholders						85%
Percentage of distribution to adviser as an incentive fee						15%
Minimum [Member] \| Second Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
Investment company, total return						6%
Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Management fee expense			733	1,102		$ 2,805	3,238
Administrative fees expense			77	105		241	315
Incentive fee expense			1,014	$ 1,285		3,326	$ 2,339
Reimbursement of organizational and offering expenses			500			500
Reimbursement of offering expenses			308			308
Reimbursement of organizational expenses			$ 84			$ 84
Management Fee [Member] \| Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Related party transaction rate						1.50%
Percentage of payment to placement agent						100%
Administration Fee [Member] \| Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Related party transaction rate						0.08%

[1] Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively. Not annualized for periods less than one year.

Fair Value - Summary of Assets

Fair Value - Summary of Assets Measured At Fair Value On A Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 354,340	$ 420,568
Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	330,577	406,543
Preferred Equity
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	9,998
Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	13,765	14,025
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	33	50
Fair Value, Inputs, Level 1 [Member] \| Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 1 [Member] \| Preferred Equity
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Fair Value, Inputs, Level 1 [Member] \| Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	33	50
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member] \| Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member] \| Preferred Equity
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0
Fair Value, Inputs, Level 2 [Member] \| Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	354,307	420,518
Fair Value, Inputs, Level 3 [Member] \| Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	330,577	406,543
Fair Value, Inputs, Level 3 [Member] \| Preferred Equity
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	9,998
Fair Value, Inputs, Level 3 [Member] \| Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 13,732	$ 13,975

Fair Value - Summary of The Cha

Fair Value - Summary of The Changes In Fair Value Of Level 3 Assets (Detail) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended	12 Months Ended
	Sep. 30, 2024		Sep. 30, 2024	Dec. 31, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	$ 397,948		$ 420,518	$ 532,813
Net realized gain	0		41	12
Net change in unrealized gain (loss)	(182)		(189)	(8,972)
Purchase of investment securities*	19,011	[1]	24,197	116,416	[2]
Proceeds from dispositions of investment securities	(62,470)		(90,260)	(219,751)
Transfers into Level 3	0		0	0
Transfers out of Level 3	0		0	0
Closing balance	354,307		354,307	420,518
Net change in unrealized gain (loss)	(182)		(13)	(8,840)
Bank Debt/Senior Secured Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	383,948		406,543	532,753
Net realized gain	0		41	12
Net change in unrealized gain (loss)	(421)		(445)	(1,678)
Purchase of investment securities*	9,403	[1]	14,581	95,190	[2]
Proceeds from dispositions of investment securities	(62,353)		(90,143)	(219,734)
Transfers into Level 3	0		0	0
Transfers out of Level 3	0		0	0
Closing balance	330,577		330,577	406,543
Net change in unrealized gain (loss)	(421)		(269)	(1,534)
Preferred Equity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	0		0
Net realized gain	0		0
Net change in unrealized gain (loss)	507		507
Purchase of investment securities*	9,491	[1]	9,491
Proceeds from dispositions of investment securities	0		0
Transfers into Level 3	0		0
Transfers out of Level 3	0		0
Closing balance	9,998		9,998	0
Net change in unrealized gain (loss)	507		507
Common Equity/Equity Interests/Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	14,000		13,975	60
Net realized gain	0		0	0
Net change in unrealized gain (loss)	(268)		(251)	(7,294)
Purchase of investment securities*	117	[1]	125	21,226	[2]
Proceeds from dispositions of investment securities	(117)		(117)	(17)
Transfers into Level 3	0		0	0
Transfers out of Level 3	0		0	0
Closing balance	13,732		13,732	13,975
Net change in unrealized gain (loss)	$ (268)		$ (251)	$ (7,306)

[1] Includes PIK capitalization and accretion of discount Includes PIK capitalization and accretion of discount

Fair Value - Summary of Quantit

Fair Value - Summary of Quantitative Information About The Company's Level 3 Asset Fair Value Measurements (Detail) - Fair Value, Inputs, Level 3 [Member] $ in Thousands	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Bank Debt/Senior Secured Loans \| Valuation, Income Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	$ 330,577	$ 406,543
Preferred Equity [Member] \| Valuation, Income Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	9,998
Common Equity/Equity Interests/Warrants \| Transaction Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	224
Common Equity/Equity Interests/Warrants \| Measurement Ebitda Multiple \| Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	13,492	13,958
Common Equity/Equity Interests/Warrants \| Valuation, Market Approach [Member] \| Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	$ 16	$ 17
Minimum [Member] \| Bank Debt/Senior Secured Loans \| Valuation, Income Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	9.6	10
Minimum [Member] \| Preferred Equity [Member] \| Valuation, Market Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	9
Minimum [Member] \| Common Equity/Equity Interests/Warrants \| Measurement Ebitda Multiple \| Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	5.5	5.5
Minimum [Member] \| Common Equity/Equity Interests/Warrants \| Valuation, Market Approach [Member] \| Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	18.3	18.9
Maximum [Member] \| Bank Debt/Senior Secured Loans \| Valuation, Income Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	17.2	17.6
Maximum [Member] \| Preferred Equity [Member] \| Valuation, Market Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	9
Maximum [Member] \| Common Equity/Equity Interests/Warrants \| Measurement Ebitda Multiple \| Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	6.5	6.5
Maximum [Member] \| Common Equity/Equity Interests/Warrants \| Valuation, Market Approach [Member] \| Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	18.3	18.9
Weighted Average [Member] \| Bank Debt/Senior Secured Loans \| Valuation, Income Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	11.7	12.2
Weighted Average [Member] \| Preferred Equity [Member] \| Valuation, Market Approach [Member] \| Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	9
Weighted Average [Member] \| Common Equity/Equity Interests/Warrants \| Measurement Ebitda Multiple \| Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	6	6
Weighted Average [Member] \| Common Equity/Equity Interests/Warrants \| Valuation, Market Approach [Member] \| Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	18.3	18.9

Fair Value - Summary of Quant_2

Fair Value - Summary of Quantitative Information About The Company's Level 3 Asset Fair Value Measurements (Parenthetical) (Details) - $ / shares		Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset valued per share	[1]	$ 10.31	$ 10.04	$ 10.64	$ 10.33
Fair Value, Inputs, Level 3 [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset valued per share		$ 2.18

[1] Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively.

Fair Value - Additional informa

Fair Value - Additional information (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
SPV Facility [Member]
Line of Credit Facility [Line Items]
Line of credit facility, Fair value of amount outstanding	$ 226,118	$ 170,800
Subscription Facility [Member]
Line of Credit Facility [Line Items]
Line of credit facility, Fair value of amount outstanding	$ 0	$ 0

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Thousands				9 Months Ended	12 Months Ended
	Aug. 02, 2024	Dec. 22, 2023	Feb. 27, 2019	Sep. 30, 2024	Dec. 31, 2023
Line of Credit Facility [Line Items]
Long term debt weighted average interest over a period of time				8.08%	8.08%
Line of credit facility, average outstanding amount				$ 226,118	$ 338,126
DB Facility [Member]
Line of Credit Facility [Line Items]
Line Of Credit Facility Maximum Borrowing Capacity				226,118
SPV Facility [Member]
Line of Credit Facility [Line Items]
Line Of Credit Facility Maximum Borrowing Capacity			$ 261,388
East West Bank [Member] \| Subscription Facility [Member]
Line of Credit Facility [Line Items]
Line Of Credit Facility Maximum Borrowing Capacity		$ 32,000
Long-Term Line of Credit				$ 0
Line of credit facility, expiration date		Dec. 31, 2024
Deutsche Bank AG, New York [Member] \| DB Facility [Member]
Line of Credit Facility [Line Items]
Line Of Credit Facility Maximum Borrowing Capacity	$ 226,118
Line of credit facility, expiration date	Aug. 02, 2027
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] \| SPV Facility [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Basis Spread on Variable Rate			2.70%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] \| East West Bank [Member] \| Subscription Facility [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Basis Spread on Variable Rate		2.95%
JPMorgan Chase Bank [Member] \| SCP Private Credit Income BDC SPV LLC [Member] \| SPV Facility [Member]
Line of Credit Facility [Line Items]
Line of credit facility, expiration date			Aug. 15, 2024

Commitments and Contingencies -

Commitments and Contingencies - Summary of Unfunded Commitments (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	$ 6,167	$ 14,730
iCIMS, Inc. [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,932	2,308
RxSense Holdings LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,558	1,558
Foundation Consumer Brands, LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	967	967
ENS Holdings III Corp. & ES Opco USA LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	502	717
Ultimate Baked Goods Midco LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	414	749
TAUC Management, LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	385	385
Transportation Insight, Inc. [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	235	0
CC SAG Holdings Corp. (Spectrum Automotive) [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	174	174
High Street Buyer, Inc. [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	1,890
Nexus Intermediate III, LLC (Vortex) [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	1,264
Kid Distro Holdings, LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	1,121
GSM Acquisition Corp. [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	1,101
Basic Fun, Inc. [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	960
Kaseya, Inc. [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	625
SunMed Group Holdings, LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	515
Vessco Midco Holdings, LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	$ 0	$ 396

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Unfunded commitments	$ 6,167	$ 14,730
Revolving Term Loans [Member]
Unfunded commitments	$ 6,167	$ 14,730

Unitholders' Capital - Summary

Unitholders' Capital - Summary of Limited Liability Company Unit Holders Capital (Detail) - shares		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Schedule Of Members Equity [Line Items]
Units at beginning of period		26,710,775	25,190,253	26,710,775	18,992,563
Units issued		0	0	0	6,197,690
Units redeemed		(8,178,256)	0	(8,178,256)	0
Units issued and outstanding at end of period	[1]	18,532,519	25,190,253	18,532,519	25,190,253

[1] Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively.

Financial Highlights - Summary

Financial Highlights - Summary of Investment Company, Financial Highlights (Detail) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Per Share Data:
Net asset value per Unit, beginning of period	[1]	$ 10.04	$ 10.33
Net investment income	[1]	0.71	0.89
Net realized and unrealized gain (loss)	[1],[2]	0.04	(0.31)
Net increase in Unitholders' capital resulting from operations	[1]	0.75	0.58
Distributions to Unitholders:
From distributable earnings	[1]	(0.48)	(0.27)
Net asset value per unit, end of period	[1]	$ 10.31	$ 10.64
Total Return	[1],[3],[4]	7.47%	5.61%
Unitholders' capital, end of year	[1]	$ 191,008	$ 267,973
Units issued and outstanding at end of period	[1]	18,532,519	25,190,253
Ratios to average net assets of Unitholders' Capital:
Net investment income (loss)	[1],[4]	7.02%	8.57%
Operating expenses	[1],[4]	2.57%	2.63%
Interest and other credit facility expenses	[1],[4]	4.15%	7.11%
Total expenses	[1],[4]	6.72%	9.74%
Average debt outstanding	[1],[4]	$ 169,115	$ 274,782
Portfolio turnover ratio	[1],[4]	5.30%	15.90%

[1] Calculated using the average units outstanding method. Weighted average Units outstanding for the nine months ended September 30, 2024 and September 30, 2023 were 26,591,385 and 24,077,997 , respectively. Includes the impact of the different Unit amounts used in calculating per Unit data as a result of calculating certain per Unit data based upon the weighted average Units outstanding during the period and certain per Unit data based on the Units outstanding as of a period end. Calculated as the change in net asset value (“NAV”) per Unit during the period plus distributions declared per Unit, divided by the beginning NAV per Unit. Total return does not include a sales load. Not annualized for periods less than one year.

Financial Highlights - Summar_2

Financial Highlights - Summary of Investment Company, Financial Highlights (Parenthetical) (Detail) - shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Investment Company, Financial Highlights [Abstract]
Weighted average limited liability company units outstanding	26,591,385	24,077,997

Income Tax Information and Dist

Income Tax Information and Distributions to Unitholders and Other Tax Information - Summary of Investment Company Distribution to Shareholders (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Investment Company, Tax Information and Distributions to Unitholders [Line Items]
From net investment income	$ 7,640	$ 6,537	$ 12,640	$ 6,537

Income Tax Information and Di_2

Income Tax Information and Distributions to Unitholders and Other Tax Information - Summary of Total Accumulated Earnings Loss on a Tax Basis (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Schedule of total accumulated earnings (loss) on a tax basis [Line Items]
Total tax accumulated earnings (loss)	$ (2,925)	$ (9,132)

Subsequent Events (Additional I

Subsequent Events (Additional Information) (Details) - DB Facility - USD ($) $ in Thousands	Aug. 02, 2024	Sep. 30, 2024
Subsequent Event [Line Items]
Total Commitment		$ 226,118
Deutsche Bank AG, New York
Subsequent Event [Line Items]
Total Commitment	$ 226,118
Maturity Date	Aug. 02, 2027